date
Note that the current default version of R is 3.6.1.
Loading required package: network
network: Classes for Relational Data
Version 1.15 created on 2019-04-01.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
                    Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Martina Morris, University of Washington
                    Skye Bender-deMoll, University of Washington
 For citation information, type citation("network").
 Type help("network-package") to get started.


networkDynamic: version 0.10.0, created on 2019-04-04
Copyright (c) 2019, Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Skye Bender-deMoll, University of Washington
                    with contributions from
                    Zack Almquist, University of California -- Irvine
                    David R. Hunter, Penn State University
                    Li Wang
                    Kirk Li, University of Washington
                    Steven M. Goodreau, University of Washington
                    Jeffrey Horner
                    Martina Morris, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("networkDynamic").

Loading required package: statnet.common

Attaching package: ‘statnet.common’

The following object is masked from ‘package:base’:

    order

sna: Tools for Social Network Analysis
Version 2.4 created on 2016-07-23.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
 For citation information, type citation("sna").
 Type help(package="sna") to get started.


ergm: version 3.10.4, created on 2019-06-10
Copyright (c) 2019, Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Carter T. Butts, University of California -- Irvine
                    Steven M. Goodreau, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Martina Morris, University of Washington
                    with contributions from
                    Li Wang
                    Kirk Li, University of Washington
                    Skye Bender-deMoll, University of Washington
                    Chad Klumb
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("ergm").

NOTE: Versions before 3.6.1 had a bug in the implementation of the bd()
constriant which distorted the sampled distribution somewhat. In
addition, Sampson's Monks datasets had mislabeled vertices. See the
NEWS and the documentation for more details.

NOTE: Some common term arguments pertaining to vertex attribute and
level selection have changed in 3.10.0. See terms help for more
details. Use ‘options(ergm.term=list(version="3.9.4"))’ to use old
behavior.


tergm: version 3.6.1, created on 2019-06-12
Copyright (c) 2019, Pavel N. Krivitsky, University of Wollongong
                    Mark S. Handcock, University of California -- Los Angeles
                    with contributions from
                    David R. Hunter, Penn State University
                    Steven M. Goodreau, University of Washington
                    Martina Morris, University of Washington
                    Nicole Bohme Carnegie, New York University
                    Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Skye Bender-deMoll
                    Li Wang
                    Kirk Li, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("tergm").

Starting maximum pseudolikelihood estimation (MPLE):
Evaluating the predictor and response matrix.
Maximizing the pseudolikelihood.
Finished MPLE.
Starting Monte Carlo maximum likelihood estimation (MCMLE):
Iteration 1 of at most 500:
Optimizing with step length 0.397256593755835.
The log-likelihood improved by 3.319.
Iteration 2 of at most 500:
Optimizing with step length 0.645737478373437.
The log-likelihood improved by 2.927.
Iteration 3 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.9618.
Step length converged once. Increasing MCMC sample size.
Iteration 4 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.7959.
Step length converged twice. Stopping.
Finished MCMLE.
This model was fit using MCMC.  To examine model diagnostics and check
for degeneracy, use the mcmc.diagnostics() function.
 degree0  degree1  degree2  degree3  degree4  degree5  degree6  degree7 
       5       20     1287     1021      786      338      381      352 
 degree8  degree9 degree10 degree11 degree12 degree13 degree14 degree15 
     290      220      131       86       45       19       10        4 
degree16 degree17 degree18 
       2        2        1 
1 
disease_progression 
H-positive risk:  887 875 117 847 446 130 872 463 130 59 122 52 
H-negative risk:  875 887 872 847 463 446 130 117 122 130 52 59 
New BC onsets:  0
BC status:  5000 
BC subtype:  5000 

clinical_engagement 
diagnosis 
demography 
48 new agents 
2 
disease_progression 
H-positive risk:  888 880 118 844 441 132 873 454 134 59 122 55 
H-negative risk:  880 888 873 844 454 441 132 118 122 134 55 59 
New BC onsets:  2
BC status:  4998 2 
BC subtype:  4998 2 

clinical_engagement 
diagnosis 
demography 
61 new agents 
3 
disease_progression 
H-positive risk:  891 879 118 839 443 132 882 445 134 58 126 53 
H-negative risk:  879 891 882 839 445 443 132 118 126 134 53 58 
New BC onsets:  6
BC status:  4994 6 
BC subtype:  4994 5 1 

clinical_engagement 
diagnosis 
demography 
40 new agents 
4 
disease_progression 
H-positive risk:  894 883 120 840 442 132 876 442 133 59 126 53 
H-negative risk:  883 894 876 840 442 442 132 120 126 133 53 59 
New BC onsets:  6
BC status:  4994 6 
BC subtype:  4994 5 1 

clinical_engagement 
diagnosis 
demography 
52 new agents 
5 
disease_progression 
H-positive risk:  893 884 122 843 438 131 880 436 134 59 127 53 
H-negative risk:  884 893 880 843 436 438 131 122 127 134 53 59 
New BC onsets:  6
BC status:  4994 6 
BC subtype:  4994 5 1 

clinical_engagement 
diagnosis 
demography 
60 new agents 
6 
disease_progression 
H-positive risk:  899 890 123 847 435 131 874 429 133 58 128 53 
H-negative risk:  890 899 874 847 429 435 131 123 128 133 53 58 
New BC onsets:  8
BC status:  4992 8 
BC subtype:  4992 6 2 

clinical_engagement 
diagnosis 
demography 
66 new agents 
7 
disease_progression 
H-positive risk:  903 899 125 840 434 130 875 422 133 58 127 54 
H-negative risk:  899 903 875 840 422 434 130 125 127 133 54 58 
New BC onsets:  11
BC status:  4989 11 
BC subtype:  4989 9 2 

clinical_engagement 
diagnosis 
demography 
71 new agents 
8 
disease_progression 
H-positive risk:  906 903 124 835 429 131 875 423 135 56 127 56 
H-negative risk:  903 906 875 835 423 429 131 124 127 135 56 56 
New BC onsets:  13
BC status:  4987 13 
BC subtype:  4987 11 2 

clinical_engagement 
diagnosis 
demography 
61 new agents 
9 
disease_progression 
H-positive risk:  909 916 126 832 423 133 878 417 131 53 127 55 
H-negative risk:  916 909 878 832 417 423 133 126 127 131 55 53 
New BC onsets:  13
BC status:  4987 13 
BC subtype:  4987 11 2 

clinical_engagement 
diagnosis 
demography 
58 new agents 
10 
disease_progression 
H-positive risk:  912 922 127 829 418 131 881 412 133 52 128 55 
H-negative risk:  922 912 881 829 412 418 131 127 128 133 55 52 
New BC onsets:  15
BC status:  4985 15 
BC subtype:  4985 13 2 

clinical_engagement 
diagnosis 
demography 
55 new agents 
11 
disease_progression 
H-positive risk:  917 930 128 829 412 131 880 405 133 53 128 54 
H-negative risk:  930 917 880 829 405 412 131 128 128 133 54 53 
New BC onsets:  14
BC status:  4986 14 
BC subtype:  4986 12 2 

clinical_engagement 
diagnosis 
demography 
72 new agents 
12 
disease_progression 
H-positive risk:  924 931 131 831 408 133 880 400 129 51 127 55 
H-negative risk:  931 924 880 831 400 408 133 131 127 129 55 51 
New BC onsets:  17
BC status:  4983 17 
BC subtype:  4983 15 2 

clinical_engagement 
diagnosis 
demography 
57 new agents 
13 
disease_progression 
H-positive risk:  848 858 116 903 402 123 963 394 142 50 145 56 
H-negative risk:  858 848 963 903 394 402 123 116 145 142 56 50 
New BC onsets:  22
BC status:  4978 22 
BC subtype:  4978 19 3 

clinical_engagement 
diagnosis 
demography 
213 new agents 
14 
disease_progression 
H-positive risk:  876 889 117 877 399 125 911 419 132 56 137 62 
H-negative risk:  889 876 911 877 419 399 125 117 137 132 62 56 
New BC onsets:  28
BC status:  4972 28 
BC subtype:  4972 21 7 

clinical_engagement 
diagnosis 
demography 
72 new agents 
15 
disease_progression 
H-positive risk:  880 898 118 878 393 124 914 418 130 53 136 58 
H-negative risk:  898 880 914 878 418 393 124 118 136 130 58 53 
New BC onsets:  33
BC status:  4967 33 
BC subtype:  4967 26 7 

clinical_engagement 
diagnosis 
demography 
64 new agents 
16 
disease_progression 
H-positive risk:  888 904 115 877 398 124 902 415 130 52 137 58 
H-negative risk:  904 888 902 877 415 398 124 115 137 130 58 52 
New BC onsets:  37
BC status:  4963 37 
BC subtype:  4963 30 7 

clinical_engagement 
diagnosis 
demography 
39 new agents 
17 
disease_progression 
H-positive risk:  893 901 116 877 393 125 905 414 130 51 138 57 
H-negative risk:  901 893 905 877 414 393 125 116 138 130 57 51 
New BC onsets:  39
BC status:  4961 39 
BC subtype:  4961 32 7 

clinical_engagement 
diagnosis 
demography 
55 new agents 
18 
disease_progression 
H-positive risk:  894 903 117 874 397 125 907 408 128 51 138 58 
H-negative risk:  903 894 907 874 408 397 125 117 138 128 58 51 
New BC onsets:  40
BC status:  4960 40 
BC subtype:  4960 33 7 

clinical_engagement 
diagnosis 
demography 
69 new agents 
19 
disease_progression 
H-positive risk:  898 906 118 869 394 128 907 405 127 52 139 57 
H-negative risk:  906 898 907 869 405 394 128 118 139 127 57 52 
New BC onsets:  45
BC status:  4955 45 
BC subtype:  4955 34 11 

clinical_engagement 
diagnosis 
demography 
57 new agents 
20 
disease_progression 
H-positive risk:  901 908 117 874 384 130 910 401 125 54 140 56 
H-negative risk:  908 901 910 874 401 384 130 117 140 125 56 54 
New BC onsets:  46
BC status:  4954 46 
BC subtype:  4954 35 11 

clinical_engagement 
diagnosis 
demography 
72 new agents 
21 
disease_progression 
H-positive risk:  906 913 117 874 382 135 906 395 123 52 141 56 
H-negative risk:  913 906 906 874 395 382 135 117 141 123 56 52 
New BC onsets:  47
BC status:  4953 47 
BC subtype:  4953 36 11 

clinical_engagement 
diagnosis 
demography 
61 new agents 
22 
disease_progression 
H-positive risk:  917 915 117 870 381 135 901 396 124 51 139 54 
H-negative risk:  915 917 901 870 396 381 135 117 139 124 54 51 
New BC onsets:  46
BC status:  4954 46 
BC subtype:  4954 36 10 

clinical_engagement 
diagnosis 
demography 
77 new agents 
23 
disease_progression 
H-positive risk:  926 920 120 867 375 134 910 391 118 48 138 53 
H-negative risk:  920 926 910 867 391 375 134 120 138 118 53 48 
New BC onsets:  46
BC status:  4954 46 
BC subtype:  4954 36 10 

clinical_engagement 
diagnosis 
demography 
61 new agents 
24 
disease_progression 
H-positive risk:  931 924 121 858 373 132 913 391 117 48 138 54 
H-negative risk:  924 931 913 858 391 373 132 121 138 117 54 48 
New BC onsets:  45
BC status:  4955 45 
BC subtype:  4955 35 10 

clinical_engagement 
diagnosis 
demography 
66 new agents 
25 
disease_progression 
H-positive risk:  851 854 115 935 374 116 990 386 132 49 144 54 
H-negative risk:  854 851 990 935 386 374 116 115 144 132 54 49 
New BC onsets:  49
BC status:  4951 49 
BC subtype:  4951 38 11 

clinical_engagement 
diagnosis 
demography 
165 new agents 
26 
disease_progression 
H-positive risk:  864 876 118 896 400 122 945 403 128 53 136 59 
H-negative risk:  876 864 945 896 403 400 122 118 136 128 59 53 
New BC onsets:  51
BC status:  4949 51 
BC subtype:  4949 40 11 

clinical_engagement 
diagnosis 
demography 
72 new agents 
27 
disease_progression 
H-positive risk:  869 876 118 897 399 125 943 398 124 53 139 59 
H-negative risk:  876 869 943 897 398 399 125 118 139 124 59 53 
New BC onsets:  52
BC status:  4948 52 
BC subtype:  4948 41 11 

clinical_engagement 
diagnosis 
demography 
65 new agents 
28 
disease_progression 
H-positive risk:  870 881 120 890 395 126 945 397 121 53 143 59 
H-negative risk:  881 870 945 890 397 395 126 120 143 121 59 53 
New BC onsets:  54
BC status:  4946 54 
BC subtype:  4946 41 13 

clinical_engagement 
diagnosis 
demography 
70 new agents 
29 
disease_progression 
H-positive risk:  865 883 122 898 395 126 934 402 125 51 141 58 
H-negative risk:  883 865 934 898 402 395 126 122 141 125 58 51 
New BC onsets:  55
BC status:  4945 55 
BC subtype:  4945 42 13 

clinical_engagement 
diagnosis 
demography 
55 new agents 
30 
disease_progression 
H-positive risk:  870 883 125 892 394 127 934 401 124 50 140 60 
H-negative risk:  883 870 934 892 401 394 127 125 140 124 60 50 
New BC onsets:  57
BC status:  4943 57 
BC subtype:  4943 44 13 

clinical_engagement 
diagnosis 
demography 
71 new agents 
31 
disease_progression 
H-positive risk:  876 880 128 890 384 126 943 399 127 48 139 60 
H-negative risk:  880 876 943 890 399 384 126 128 139 127 60 48 
New BC onsets:  54
BC status:  4946 54 
BC subtype:  4946 43 11 

clinical_engagement 
diagnosis 
demography 
63 new agents 
32 
disease_progression 
H-positive risk:  880 884 129 883 386 129 943 394 124 50 138 60 
H-negative risk:  884 880 943 883 394 386 129 129 138 124 60 50 
New BC onsets:  54
BC status:  4946 54 
BC subtype:  4946 44 10 

clinical_engagement 
diagnosis 
demography 
54 new agents 
33 
disease_progression 
H-positive risk:  880 887 126 883 386 128 940 393 125 50 142 60 
H-negative risk:  887 880 940 883 393 386 128 126 142 125 60 50 
New BC onsets:  53
BC status:  4947 53 
BC subtype:  4947 44 9 

clinical_engagement 
diagnosis 
demography 
58 new agents 
34 
disease_progression 
H-positive risk:  881 886 125 882 385 130 945 394 125 48 142 57 
H-negative risk:  886 881 945 882 394 385 130 125 142 125 57 48 
New BC onsets:  52
BC status:  4948 52 
BC subtype:  4948 42 10 

clinical_engagement 
diagnosis 
demography 
68 new agents 
35 
disease_progression 
H-positive risk:  875 886 127 881 381 127 943 400 129 49 143 59 
H-negative risk:  886 875 943 881 400 381 127 127 143 129 59 49 
New BC onsets:  51
BC status:  4949 51 
BC subtype:  4949 42 9 

clinical_engagement 
diagnosis 
demography 
58 new agents 
36 
disease_progression 
H-positive risk:  876 892 127 885 374 128 945 395 127 48 146 57 
H-negative risk:  892 876 945 885 395 374 128 127 146 127 57 48 
New BC onsets:  55
BC status:  4945 55 
BC subtype:  4945 45 10 

clinical_engagement 
diagnosis 
demography 
57 new agents 
37 
disease_progression 
H-positive risk:  816 821 120 960 370 121 1004 391 136 49 156 56 
H-negative risk:  821 816 1004 960 391 370 121 120 156 136 56 49 
New BC onsets:  58
BC status:  4942 58 
BC subtype:  4942 48 10 

clinical_engagement 
diagnosis 
demography 
161 new agents 
38 
disease_progression 
H-positive risk:  841 836 123 916 388 120 969 413 130 52 151 61 
H-negative risk:  836 841 969 916 413 388 120 123 151 130 61 52 
New BC onsets:  58
BC status:  4942 58 
BC subtype:  4942 47 11 

clinical_engagement 
diagnosis 
demography 
94 new agents 
39 
disease_progression 
H-positive risk:  847 840 124 917 384 122 965 411 130 47 154 59 
H-negative risk:  840 847 965 917 411 384 122 124 154 130 59 47 
New BC onsets:  59
BC status:  4941 59 
BC subtype:  4941 48 11 

clinical_engagement 
diagnosis 
demography 
70 new agents 
40 
disease_progression 
H-positive risk:  851 844 126 923 376 125 961 406 130 46 154 58 
H-negative risk:  844 851 961 923 406 376 125 126 154 130 58 46 
New BC onsets:  62
BC status:  4938 62 
BC subtype:  4938 49 13 

clinical_engagement 
diagnosis 
demography 
67 new agents 
41 
disease_progression 
H-positive risk:  855 849 125 925 372 124 962 401 129 45 159 54 
H-negative risk:  849 855 962 925 401 372 124 125 159 129 54 45 
New BC onsets:  63
BC status:  4937 63 
BC subtype:  4937 50 13 

clinical_engagement 
diagnosis 
demography 
74 new agents 
42 
disease_progression 
H-positive risk:  862 852 127 919 370 123 965 392 129 47 158 56 
H-negative risk:  852 862 965 919 392 370 123 127 158 129 56 47 
New BC onsets:  64
BC status:  4936 64 
BC subtype:  4936 52 12 

clinical_engagement 
diagnosis 
demography 
52 new agents 
43 
disease_progression 
H-positive risk:  865 850 126 920 371 121 969 392 130 45 157 54 
H-negative risk:  850 865 969 920 392 371 121 126 157 130 54 45 
New BC onsets:  67
BC status:  4933 67 
BC subtype:  4933 55 12 

clinical_engagement 
diagnosis 
demography 
67 new agents 
44 
disease_progression 
H-positive risk:  867 858 129 920 365 121 958 396 134 44 156 52 
H-negative risk:  858 867 958 920 396 365 121 129 156 134 52 44 
New BC onsets:  68
BC status:  4932 68 
BC subtype:  4932 56 12 

clinical_engagement 
diagnosis 
demography 
52 new agents 
45 
disease_progression 
H-positive risk:  869 863 129 929 355 122 961 391 134 43 153 51 
H-negative risk:  863 869 961 929 391 355 122 129 153 134 51 43 
New BC onsets:  67
BC status:  4933 67 
BC subtype:  4933 55 12 

clinical_engagement 
diagnosis 
demography 
59 new agents 
46 
disease_progression 
H-positive risk:  873 869 128 921 351 123 970 387 132 45 150 51 
H-negative risk:  869 873 970 921 387 351 123 128 150 132 51 45 
New BC onsets:  71
BC status:  4929 71 
BC subtype:  4929 59 12 

clinical_engagement 
diagnosis 
demography 
71 new agents 
47 
disease_progression 
H-positive risk:  876 873 124 923 355 124 968 380 130 44 152 51 
H-negative risk:  873 876 968 923 380 355 124 124 152 130 51 44 
New BC onsets:  74
BC status:  4926 74 
BC subtype:  4926 61 13 

clinical_engagement 
diagnosis 
demography 
61 new agents 
48 
disease_progression 
H-positive risk:  873 873 123 920 358 125 969 381 127 46 153 52 
H-negative risk:  873 873 969 920 381 358 125 123 153 127 52 46 
New BC onsets:  79
BC status:  4921 79 
BC subtype:  4921 65 14 

clinical_engagement 
diagnosis 
demography 
68 new agents 
49 
disease_progression 
H-positive risk:  822 820 119 977 355 120 1027 370 131 47 159 53 
H-negative risk:  820 822 1027 977 370 355 120 119 159 131 53 47 
New BC onsets:  79
BC status:  4921 79 
BC subtype:  4921 65 14 

clinical_engagement 
diagnosis 
demography 
137 new agents 
50 
disease_progression 
H-positive risk:  829 833 125 951 367 122 998 386 128 50 159 52 
H-negative risk:  833 829 998 951 386 367 122 125 159 128 52 50 
New BC onsets:  79
BC status:  4921 79 
BC subtype:  4921 62 17 

clinical_engagement 
diagnosis 
demography 
66 new agents 
51 
disease_progression 
H-positive risk:  828 839 125 946 368 120 1004 381 129 51 157 52 
H-negative risk:  839 828 1004 946 381 368 120 125 157 129 52 51 
New BC onsets:  81
BC status:  4919 81 
BC subtype:  4919 62 19 

clinical_engagement 
diagnosis 
demography 
61 new agents 
52 
disease_progression 
H-positive risk:  827 841 126 950 370 120 995 379 131 53 158 50 
H-negative risk:  841 827 995 950 379 370 120 126 158 131 50 53 
New BC onsets:  80
BC status:  4920 80 
BC subtype:  4920 61 19 

clinical_engagement 
diagnosis 
demography 
71 new agents 
53 
disease_progression 
H-positive risk:  833 838 126 950 367 125 990 379 129 52 161 50 
H-negative risk:  838 833 990 950 379 367 125 126 161 129 50 52 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 63 21 

clinical_engagement 
diagnosis 
demography 
63 new agents 
54 
disease_progression 
H-positive risk:  829 843 127 944 371 123 995 377 126 52 161 52 
H-negative risk:  843 829 995 944 377 371 123 127 161 126 52 52 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 67 21 

clinical_engagement 
diagnosis 
demography 
72 new agents 
55 
disease_progression 
H-positive risk:  830 845 128 943 374 126 995 370 124 50 164 51 
H-negative risk:  845 830 995 943 370 374 126 128 164 124 51 50 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 66 21 

clinical_engagement 
diagnosis 
demography 
62 new agents 
56 
disease_progression 
H-positive risk:  836 848 127 940 370 126 998 362 126 50 166 51 
H-negative risk:  848 836 998 940 362 370 126 127 166 126 51 50 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 64 22 

clinical_engagement 
diagnosis 
demography 
71 new agents 
57 
disease_progression 
H-positive risk:  839 851 129 947 370 124 982 369 126 49 166 48 
H-negative risk:  851 839 982 947 369 370 124 129 166 126 48 49 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 65 19 

clinical_engagement 
diagnosis 
demography 
58 new agents 
58 
disease_progression 
H-positive risk:  847 853 130 950 365 124 975 365 125 51 164 51 
H-negative risk:  853 847 975 950 365 365 124 130 164 125 51 51 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 65 19 

clinical_engagement 
diagnosis 
demography 
60 new agents 
59 
disease_progression 
H-positive risk:  847 857 129 949 359 127 976 368 122 49 164 53 
H-negative risk:  857 847 976 949 368 359 127 129 164 122 53 49 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 66 20 

clinical_engagement 
diagnosis 
demography 
65 new agents 
60 
disease_progression 
H-positive risk:  851 859 130 951 358 122 972 372 122 51 159 53 
H-negative risk:  859 851 972 951 372 358 122 130 159 122 53 51 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 68 21 

clinical_engagement 
diagnosis 
demography 
65 new agents 
61 
disease_progression 
H-positive risk:  791 798 123 1013 359 110 1037 367 132 52 167 51 
H-negative risk:  798 791 1037 1013 367 359 110 123 167 132 51 52 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 70 22 

clinical_engagement 
diagnosis 
demography 
137 new agents 
62 
disease_progression 
H-positive risk:  805 806 122 991 362 114 1011 381 125 62 166 55 
H-negative risk:  806 805 1011 991 381 362 114 122 166 125 55 62 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 67 23 

clinical_engagement 
diagnosis 
demography 
78 new agents 
63 
disease_progression 
H-positive risk:  800 807 127 987 362 117 1015 379 129 59 161 57 
H-negative risk:  807 800 1015 987 379 362 117 127 161 129 57 59 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 67 23 

clinical_engagement 
diagnosis 
demography 
66 new agents 
64 
disease_progression 
H-positive risk:  802 805 126 990 356 117 1023 372 128 59 165 57 
H-negative risk:  805 802 1023 990 372 356 117 126 165 128 57 59 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 70 22 

clinical_engagement 
diagnosis 
demography 
60 new agents 
65 
disease_progression 
H-positive risk:  806 804 126 985 357 119 1017 374 128 59 168 57 
H-negative risk:  804 806 1017 985 374 357 119 126 168 128 57 59 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 70 23 

clinical_engagement 
diagnosis 
demography 
74 new agents 
66 
disease_progression 
H-positive risk:  806 807 129 991 349 116 1019 374 129 57 166 57 
H-negative risk:  807 806 1019 991 374 349 116 129 166 129 57 57 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 70 24 

clinical_engagement 
diagnosis 
demography 
69 new agents 
67 
disease_progression 
H-positive risk:  805 801 132 995 347 115 1021 375 130 58 166 55 
H-negative risk:  801 805 1021 995 375 347 115 132 166 130 55 58 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 71 24 

clinical_engagement 
diagnosis 
demography 
66 new agents 
68 
disease_progression 
H-positive risk:  803 799 129 993 348 115 1019 378 130 58 173 55 
H-negative risk:  799 803 1019 993 378 348 115 129 173 130 55 58 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 71 24 

clinical_engagement 
diagnosis 
demography 
66 new agents 
69 
disease_progression 
H-positive risk:  802 801 129 998 351 117 1013 377 126 58 175 53 
H-negative risk:  801 802 1013 998 377 351 117 129 175 126 53 58 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 71 24 

clinical_engagement 
diagnosis 
demography 
72 new agents 
70 
disease_progression 
H-positive risk:  808 804 129 1001 353 117 1009 372 123 58 173 53 
H-negative risk:  804 808 1009 1001 372 353 117 129 173 123 53 58 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 74 23 

clinical_engagement 
diagnosis 
demography 
67 new agents 
71 
disease_progression 
H-positive risk:  809 810 126 1002 349 120 1012 369 122 56 174 51 
H-negative risk:  810 809 1012 1002 369 349 120 126 174 122 51 56 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 74 23 

clinical_engagement 
diagnosis 
demography 
72 new agents 
72 
disease_progression 
H-positive risk:  810 819 129 1001 347 119 1007 367 123 55 175 48 
H-negative risk:  819 810 1007 1001 367 347 119 129 175 123 48 55 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 76 22 

clinical_engagement 
diagnosis 
demography 
62 new agents 
73 
disease_progression 
H-positive risk:  771 768 122 1054 347 115 1040 366 133 54 184 46 
H-negative risk:  768 771 1040 1054 366 347 115 122 184 133 46 54 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 77 24 

clinical_engagement 
diagnosis 
demography 
103 new agents 
74 
disease_progression 
H-positive risk:  772 778 120 1042 354 115 1020 380 136 55 182 46 
H-negative risk:  778 772 1020 1042 380 354 115 120 182 136 46 55 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 77 24 

clinical_engagement 
diagnosis 
demography 
73 new agents 
75 
disease_progression 
H-positive risk:  775 780 122 1035 352 119 1018 382 133 54 177 53 
H-negative risk:  780 775 1018 1035 382 352 119 122 177 133 53 54 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 79 25 

clinical_engagement 
diagnosis 
demography 
69 new agents 
76 
disease_progression 
H-positive risk:  779 783 121 1039 358 118 1010 380 131 51 178 52 
H-negative risk:  783 779 1010 1039 380 358 118 121 178 131 52 51 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 79 25 

clinical_engagement 
diagnosis 
demography 
73 new agents 
77 
disease_progression 
H-positive risk:  788 784 119 1046 357 119 1005 382 126 47 177 50 
H-negative risk:  784 788 1005 1046 382 357 119 119 177 126 50 47 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 80 23 

clinical_engagement 
diagnosis 
demography 
58 new agents 
78 
disease_progression 
H-positive risk:  790 786 119 1046 354 120 1011 376 124 48 177 49 
H-negative risk:  786 790 1011 1046 376 354 120 119 177 124 49 48 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 79 23 

clinical_engagement 
diagnosis 
demography 
65 new agents 
79 
disease_progression 
H-positive risk:  792 785 121 1046 356 121 1006 375 125 49 176 48 
H-negative risk:  785 792 1006 1046 375 356 121 121 176 125 48 49 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 79 23 

clinical_engagement 
diagnosis 
demography 
79 new agents 
80 
disease_progression 
H-positive risk:  790 792 122 1042 362 120 1011 366 122 48 176 49 
H-negative risk:  792 790 1011 1042 366 362 120 122 176 122 49 48 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 77 24 

clinical_engagement 
diagnosis 
demography 
76 new agents 
81 
disease_progression 
H-positive risk:  793 796 124 1043 358 123 1008 360 121 48 177 49 
H-negative risk:  796 793 1008 1043 360 358 123 124 177 121 49 48 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 80 24 

clinical_engagement 
diagnosis 
demography 
55 new agents 
82 
disease_progression 
H-positive risk:  788 796 126 1049 358 123 1006 358 119 51 177 49 
H-negative risk:  796 788 1006 1049 358 358 123 126 177 119 49 51 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 80 24 

clinical_engagement 
diagnosis 
demography 
73 new agents 
83 
disease_progression 
H-positive risk:  789 803 124 1050 355 125 1005 356 117 49 177 50 
H-negative risk:  803 789 1005 1050 356 355 125 124 177 117 50 49 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 78 24 

clinical_engagement 
diagnosis 
demography 
60 new agents 
84 
disease_progression 
H-positive risk:  789 803 125 1047 351 123 1007 361 120 48 175 51 
H-negative risk:  803 789 1007 1047 361 351 123 125 175 120 51 48 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 80 24 

clinical_engagement 
diagnosis 
demography 
75 new agents 
85 
disease_progression 
H-positive risk:  735 753 121 1095 349 114 1072 356 126 47 179 53 
H-negative risk:  753 735 1072 1095 356 349 114 121 179 126 53 47 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 80 24 

clinical_engagement 
diagnosis 
demography 
116 new agents 
86 
disease_progression 
H-positive risk:  748 750 123 1088 345 113 1067 361 122 53 176 54 
H-negative risk:  750 748 1067 1088 361 345 113 123 176 122 54 53 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 84 25 

clinical_engagement 
diagnosis 
demography 
82 new agents 
87 
disease_progression 
H-positive risk:  752 744 121 1091 345 113 1066 371 121 51 173 52 
H-negative risk:  744 752 1066 1091 371 345 113 121 173 121 52 51 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 87 25 

clinical_engagement 
diagnosis 
demography 
68 new agents 
88 
disease_progression 
H-positive risk:  752 745 121 1097 343 115 1066 366 120 51 170 54 
H-negative risk:  745 752 1066 1097 366 343 115 121 170 120 54 51 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 85 24 

clinical_engagement 
diagnosis 
demography 
69 new agents 
89 
disease_progression 
H-positive risk:  756 748 124 1094 337 112 1070 367 124 49 167 52 
H-negative risk:  748 756 1070 1094 367 337 112 124 167 124 52 49 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 84 24 

clinical_engagement 
diagnosis 
demography 
89 new agents 
90 
disease_progression 
H-positive risk:  753 755 124 1088 342 112 1066 368 125 48 167 52 
H-negative risk:  755 753 1066 1088 368 342 112 124 167 125 52 48 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 83 22 

clinical_engagement 
diagnosis 
demography 
73 new agents 
91 
disease_progression 
H-positive risk:  753 758 124 1085 336 114 1068 367 124 50 170 51 
H-negative risk:  758 753 1068 1085 367 336 114 124 170 124 51 50 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 82 22 

clinical_engagement 
diagnosis 
demography 
63 new agents 
92 
disease_progression 
H-positive risk:  755 772 122 1071 341 112 1069 358 130 48 171 51 
H-negative risk:  772 755 1069 1071 358 341 112 122 171 130 51 48 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 84 24 

clinical_engagement 
diagnosis 
demography 
71 new agents 
93 
disease_progression 
H-positive risk:  758 773 122 1074 333 112 1062 366 130 47 172 51 
H-negative risk:  773 758 1062 1074 366 333 112 122 172 130 51 47 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 82 24 

clinical_engagement 
diagnosis 
demography 
68 new agents 
94 
disease_progression 
H-positive risk:  751 774 124 1081 329 111 1067 362 132 47 170 52 
H-negative risk:  774 751 1067 1081 362 329 111 124 170 132 52 47 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 84 24 

clinical_engagement 
diagnosis 
demography 
71 new agents 
95 
disease_progression 
H-positive risk:  749 772 125 1084 323 113 1072 365 130 45 169 53 
H-negative risk:  772 749 1072 1084 365 323 113 125 169 130 53 45 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 86 23 

clinical_engagement 
diagnosis 
demography 
75 new agents 
96 
disease_progression 
H-positive risk:  749 771 125 1083 329 112 1076 357 130 41 174 53 
H-negative risk:  771 749 1076 1083 357 329 112 125 174 130 53 41 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 87 21 

clinical_engagement 
diagnosis 
demography 
82 new agents 
97 
disease_progression 
H-positive risk:  719 720 122 1126 331 106 1107 355 138 42 180 54 
H-negative risk:  720 719 1107 1126 355 331 106 122 180 138 54 42 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 86 21 

clinical_engagement 
diagnosis 
demography 
109 new agents 
98 
disease_progression 
H-positive risk:  714 718 120 1108 345 105 1096 376 139 41 183 55 
H-negative risk:  718 714 1096 1108 376 345 105 120 183 139 55 41 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 90 20 

clinical_engagement 
diagnosis 
demography 
59 new agents 
99 
disease_progression 
H-positive risk:  715 716 119 1112 345 105 1097 374 135 43 184 55 
H-negative risk:  716 715 1097 1112 374 345 105 119 184 135 55 43 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 88 20 

clinical_engagement 
diagnosis 
demography 
70 new agents 
100 
disease_progression 
H-positive risk:  713 722 121 1106 357 103 1094 368 138 44 183 51 
H-negative risk:  722 713 1094 1106 368 357 103 121 183 138 51 44 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 87 20 

clinical_engagement 
diagnosis 
demography 
63 new agents 
101 
disease_progression 
H-positive risk:  715 727 121 1102 361 106 1097 361 135 44 181 50 
H-negative risk:  727 715 1097 1102 361 361 106 121 181 135 50 44 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 85 19 

clinical_engagement 
diagnosis 
demography 
89 new agents 
102 
disease_progression 
H-positive risk:  712 728 119 1105 349 105 1098 364 136 47 184 53 
H-negative risk:  728 712 1098 1105 364 349 105 119 184 136 53 47 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 87 23 

clinical_engagement 
diagnosis 
demography 
81 new agents 
103 
disease_progression 
H-positive risk:  724 726 116 1104 344 107 1100 356 136 49 187 51 
H-negative risk:  726 724 1100 1104 356 344 107 116 187 136 51 49 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 87 23 

clinical_engagement 
diagnosis 
demography 
70 new agents 
104 
disease_progression 
H-positive risk:  724 728 112 1118 339 107 1104 348 134 49 189 48 
H-negative risk:  728 724 1104 1118 348 339 107 112 189 134 48 49 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 87 22 

clinical_engagement 
diagnosis 
demography 
80 new agents 
105 
disease_progression 
H-positive risk:  732 733 114 1112 341 109 1096 348 132 49 187 47 
H-negative risk:  733 732 1096 1112 348 341 109 114 187 132 47 49 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 92 22 

clinical_engagement 
diagnosis 
demography 
77 new agents 
106 
disease_progression 
H-positive risk:  737 731 117 1107 343 106 1100 345 137 47 182 48 
H-negative risk:  731 737 1100 1107 345 343 106 117 182 137 48 47 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 89 21 

clinical_engagement 
diagnosis 
demography 
79 new agents 
107 
disease_progression 
H-positive risk:  735 736 119 1100 348 106 1111 337 136 46 178 48 
H-negative risk:  736 735 1111 1100 337 348 106 119 178 136 48 46 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 89 21 

clinical_engagement 
diagnosis 
demography 
67 new agents 
108 
disease_progression 
H-positive risk:  729 739 116 1104 342 107 1109 342 135 49 181 47 
H-negative risk:  739 729 1109 1104 342 342 107 116 181 135 47 49 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 86 21 

clinical_engagement 
diagnosis 
demography 
67 new agents 
109 
disease_progression 
H-positive risk:  681 700 108 1140 347 101 1157 345 139 50 188 44 
H-negative risk:  700 681 1157 1140 345 347 101 108 188 139 44 50 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 87 21 

clinical_engagement 
diagnosis 
demography 
82 new agents 
110 
disease_progression 
H-positive risk:  678 689 108 1136 362 95 1153 356 140 51 186 46 
H-negative risk:  689 678 1153 1136 356 362 95 108 186 140 46 51 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 87 19 

clinical_engagement 
diagnosis 
demography 
93 new agents 
111 
disease_progression 
H-positive risk:  687 700 110 1129 365 93 1141 356 134 55 186 44 
H-negative risk:  700 687 1141 1129 356 365 93 110 186 134 44 55 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 86 17 

clinical_engagement 
diagnosis 
demography 
67 new agents 
112 
disease_progression 
H-positive risk:  691 702 110 1125 362 96 1144 354 133 56 186 41 
H-negative risk:  702 691 1144 1125 354 362 96 110 186 133 41 56 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 87 19 

clinical_engagement 
diagnosis 
demography 
79 new agents 
113 
disease_progression 
H-positive risk:  688 712 113 1121 361 95 1146 353 134 53 182 42 
H-negative risk:  712 688 1146 1121 353 361 95 113 182 134 42 53 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 88 19 

clinical_engagement 
diagnosis 
demography 
76 new agents 
114 
disease_progression 
H-positive risk:  691 714 113 1112 366 95 1150 349 136 50 182 42 
H-negative risk:  714 691 1150 1112 349 366 95 113 182 136 42 50 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 88 19 

clinical_engagement 
diagnosis 
demography 
64 new agents 
115 
disease_progression 
H-positive risk:  682 715 113 1112 368 94 1150 356 139 49 182 40 
H-negative risk:  715 682 1150 1112 356 368 94 113 182 139 40 49 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 85 18 

clinical_engagement 
diagnosis 
demography 
73 new agents 
116 
disease_progression 
H-positive risk:  686 711 112 1113 372 95 1139 359 139 52 183 39 
H-negative risk:  711 686 1139 1113 359 372 95 112 183 139 39 52 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 87 18 

clinical_engagement 
diagnosis 
demography 
78 new agents 
117 
disease_progression 
H-positive risk:  683 708 111 1112 377 92 1137 366 137 54 181 42 
H-negative risk:  708 683 1137 1112 366 377 92 111 181 137 42 54 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 87 17 

clinical_engagement 
diagnosis 
demography 
83 new agents 
118 
disease_progression 
H-positive risk:  691 706 115 1106 376 97 1134 363 135 54 179 44 
H-negative risk:  706 691 1134 1106 363 376 97 115 179 135 44 54 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 84 17 

clinical_engagement 
diagnosis 
demography 
76 new agents 
119 
disease_progression 
H-positive risk:  697 710 117 1107 377 96 1131 361 135 52 176 41 
H-negative risk:  710 697 1131 1107 361 377 96 117 176 135 41 52 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 87 17 

clinical_engagement 
diagnosis 
demography 
62 new agents 
120 
disease_progression 
H-positive risk:  696 710 120 1110 380 98 1119 361 135 53 176 42 
H-negative risk:  710 696 1119 1110 361 380 98 120 176 135 42 53 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 86 18 

clinical_engagement 
diagnosis 
demography 
67 new agents 
121 
disease_progression 
H-positive risk:  652 682 115 1146 379 86 1154 362 144 55 181 44 
H-negative risk:  682 652 1154 1146 362 379 86 115 181 144 44 55 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 85 17 

clinical_engagement 
diagnosis 
demography 
82 new agents 
122 
disease_progression 
H-positive risk:  650 683 113 1127 393 84 1141 385 144 57 181 42 
H-negative risk:  683 650 1141 1127 385 393 84 113 181 144 42 57 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 85 17 

clinical_engagement 
diagnosis 
demography 
79 new agents 
123 
disease_progression 
H-positive risk:  646 683 111 1128 398 85 1145 383 146 52 180 43 
H-negative risk:  683 646 1145 1128 383 398 85 111 180 146 43 52 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 84 18 

clinical_engagement 
diagnosis 
demography 
55 new agents 
124 
disease_progression 
H-positive risk:  650 674 113 1130 401 88 1141 382 148 52 177 44 
H-negative risk:  674 650 1141 1130 382 401 88 113 177 148 44 52 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 84 18 

clinical_engagement 
diagnosis 
demography 
71 new agents 
125 
disease_progression 
H-positive risk:  649 677 110 1121 398 89 1149 380 149 50 181 47 
H-negative risk:  677 649 1149 1121 380 398 89 110 181 149 47 50 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 83 18 

clinical_engagement 
diagnosis 
demography 
83 new agents 
126 
disease_progression 
H-positive risk:  651 682 110 1115 391 93 1154 374 149 48 185 48 
H-negative risk:  682 651 1154 1115 374 391 93 110 185 149 48 48 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 86 18 

clinical_engagement 
diagnosis 
demography 
73 new agents 
127 
disease_progression 
H-positive risk:  647 683 111 1119 394 96 1147 374 152 46 184 47 
H-negative risk:  683 647 1147 1119 374 394 96 111 184 152 47 46 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 85 18 

clinical_engagement 
diagnosis 
demography 
87 new agents 
128 
disease_progression 
H-positive risk:  643 695 114 1122 390 94 1144 372 154 43 181 48 
H-negative risk:  695 643 1144 1122 372 390 94 114 181 154 48 43 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 83 18 

clinical_engagement 
diagnosis 
demography 
64 new agents 
129 
disease_progression 
H-positive risk:  643 692 114 1127 387 92 1145 369 160 40 182 49 
H-negative risk:  692 643 1145 1127 369 387 92 114 182 160 49 40 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 83 19 

clinical_engagement 
diagnosis 
demography 
82 new agents 
130 
disease_progression 
H-positive risk:  654 705 111 1121 385 89 1137 363 159 42 181 53 
H-negative risk:  705 654 1137 1121 363 385 89 111 181 159 53 42 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 83 19 

clinical_engagement 
diagnosis 
demography 
56 new agents 
131 
disease_progression 
H-positive risk:  647 699 109 1123 385 92 1137 369 159 42 184 54 
H-negative risk:  699 647 1137 1123 369 385 92 109 184 159 54 42 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 80 18 

clinical_engagement 
diagnosis 
demography 
72 new agents 
132 
disease_progression 
H-positive risk:  652 694 111 1130 389 95 1131 369 152 40 186 51 
H-negative risk:  694 652 1131 1130 369 389 95 111 186 152 51 40 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 83 17 

clinical_engagement 
diagnosis 
demography 
70 new agents 
133 
disease_progression 
H-positive risk:  651 695 112 1129 388 97 1139 365 152 37 186 49 
H-negative risk:  695 651 1139 1129 365 388 97 112 186 152 49 37 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 83 19 

clinical_engagement 
diagnosis 
demography 
88 new agents 
134 
disease_progression 
H-positive risk:  649 694 110 1122 406 97 1124 371 156 39 178 54 
H-negative risk:  694 649 1124 1122 371 406 97 110 178 156 54 39 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 81 19 

clinical_engagement 
diagnosis 
demography 
88 new agents 
135 
disease_progression 
H-positive risk:  644 693 109 1120 414 97 1119 378 154 45 175 52 
H-negative risk:  693 644 1119 1120 378 414 97 109 175 154 52 45 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 81 18 

clinical_engagement 
diagnosis 
demography 
71 new agents 
136 
disease_progression 
H-positive risk:  645 698 104 1113 419 97 1127 374 155 42 177 49 
H-negative risk:  698 645 1127 1113 374 419 97 104 177 155 49 42 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 81 18 

clinical_engagement 
diagnosis 
demography 
77 new agents 
137 
disease_progression 
H-positive risk:  643 694 102 1114 417 95 1129 375 156 43 183 49 
H-negative risk:  694 643 1129 1114 375 417 95 102 183 156 49 43 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 79 19 

clinical_engagement 
diagnosis 
demography 
60 new agents 
138 
disease_progression 
H-positive risk:  636 685 105 1114 420 95 1126 383 156 45 186 49 
H-negative risk:  685 636 1126 1114 383 420 95 105 186 156 49 45 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 78 18 

clinical_engagement 
diagnosis 
demography 
76 new agents 
139 
disease_progression 
H-positive risk:  638 678 105 1108 420 99 1119 389 156 47 189 52 
H-negative risk:  678 638 1119 1108 389 420 99 105 189 156 52 47 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 81 18 

clinical_engagement 
diagnosis 
demography 
78 new agents 
140 
disease_progression 
H-positive risk:  638 673 106 1117 415 97 1119 388 158 48 188 53 
H-negative risk:  673 638 1119 1117 388 415 97 106 188 158 53 48 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 81 22 

clinical_engagement 
diagnosis 
demography 
74 new agents 
141 
disease_progression 
H-positive risk:  644 674 108 1118 413 96 1116 386 156 47 190 52 
H-negative risk:  674 644 1116 1118 386 413 96 108 190 156 52 47 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 81 22 

clinical_engagement 
diagnosis 
demography 
73 new agents 
142 
disease_progression 
H-positive risk:  644 668 110 1114 414 97 1124 388 154 48 188 51 
H-negative risk:  668 644 1124 1114 388 414 97 110 188 154 51 48 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 78 21 

clinical_engagement 
diagnosis 
demography 
60 new agents 
143 
disease_progression 
H-positive risk:  637 660 111 1130 411 97 1117 387 160 48 188 54 
H-negative risk:  660 637 1117 1130 387 411 97 111 188 160 54 48 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 76 21 

clinical_engagement 
diagnosis 
demography 
83 new agents 
144 
disease_progression 
H-positive risk:  638 660 114 1130 415 95 1109 390 158 47 188 56 
H-negative risk:  660 638 1109 1130 390 415 95 114 188 158 56 47 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 76 21 

clinical_engagement 
diagnosis 
demography 
72 new agents 
145 
disease_progression 
H-positive risk:  633 660 115 1129 410 95 1110 394 159 47 191 57 
H-negative risk:  660 633 1110 1129 394 410 95 115 191 159 57 47 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 78 19 

clinical_engagement 
diagnosis 
demography 
83 new agents 
146 
disease_progression 
H-positive risk:  626 647 117 1121 423 96 1111 405 158 49 186 61 
H-negative risk:  647 626 1111 1121 405 423 96 117 186 158 61 49 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 78 19 

clinical_engagement 
diagnosis 
demography 
76 new agents 
147 
disease_progression 
H-positive risk:  635 650 118 1119 416 93 1106 415 155 50 182 61 
H-negative risk:  650 635 1106 1119 415 416 93 118 182 155 61 50 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 77 20 

clinical_engagement 
diagnosis 
demography 
72 new agents 
148 
disease_progression 
H-positive risk:  640 651 119 1110 416 93 1115 411 158 50 180 57 
H-negative risk:  651 640 1115 1110 411 416 93 119 180 158 57 50 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 77 20 

clinical_engagement 
diagnosis 
demography 
78 new agents 
149 
disease_progression 
H-positive risk:  652 651 120 1105 409 92 1105 414 159 51 181 61 
H-negative risk:  651 652 1105 1105 414 409 92 120 181 159 61 51 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 76 21 

clinical_engagement 
diagnosis 
demography 
61 new agents 
150 
disease_progression 
H-positive risk:  654 640 119 1115 407 93 1111 408 162 50 179 62 
H-negative risk:  640 654 1111 1115 408 407 93 119 179 162 62 50 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 74 21 

clinical_engagement 
diagnosis 
demography 
67 new agents 
151 
disease_progression 
H-positive risk:  657 647 117 1122 406 90 1104 401 165 51 176 64 
H-negative risk:  647 657 1104 1122 401 406 90 117 176 165 64 51 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 73 22 

clinical_engagement 
diagnosis 
demography 
67 new agents 
152 
disease_progression 
H-positive risk:  653 641 115 1119 405 93 1109 404 165 51 179 66 
H-negative risk:  641 653 1109 1119 404 405 93 115 179 165 66 51 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 75 20 

clinical_engagement 
diagnosis 
demography 
89 new agents 
153 
disease_progression 
H-positive risk:  661 646 110 1118 404 92 1110 402 161 52 180 64 
H-negative risk:  646 661 1110 1118 402 404 92 110 180 161 64 52 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 75 20 

clinical_engagement 
diagnosis 
demography 
77 new agents 
154 
disease_progression 
H-positive risk:  663 648 107 1105 405 94 1113 404 162 53 181 65 
H-negative risk:  648 663 1113 1105 404 405 94 107 181 162 65 53 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 77 20 

clinical_engagement 
diagnosis 
demography 
71 new agents 
155 
disease_progression 
H-positive risk:  656 652 106 1104 400 94 1122 407 162 50 183 64 
H-negative risk:  652 656 1122 1104 407 400 94 106 183 162 64 50 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 78 20 

clinical_engagement 
diagnosis 
demography 
65 new agents 
156 
disease_progression 
H-positive risk:  658 649 103 1106 405 96 1124 401 161 49 184 64 
H-negative risk:  649 658 1124 1106 401 405 96 103 184 161 64 49 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 79 22 

clinical_engagement 
diagnosis 
demography 
67 new agents 
157 
disease_progression 
H-positive risk:  659 649 105 1100 411 97 1121 402 162 50 179 65 
H-negative risk:  649 659 1121 1100 402 411 97 105 179 162 65 50 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 82 22 

clinical_engagement 
diagnosis 
demography 
83 new agents 
158 
disease_progression 
H-positive risk:  661 646 101 1100 419 95 1112 404 162 53 177 70 
H-negative risk:  646 661 1112 1100 404 419 95 101 177 162 70 53 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 83 21 

clinical_engagement 
diagnosis 
demography 
74 new agents 
159 
disease_progression 
H-positive risk:  671 634 98 1110 416 97 1110 400 160 53 181 70 
H-negative risk:  634 671 1110 1110 400 416 97 98 181 160 70 53 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 82 20 

clinical_engagement 
diagnosis 
demography 
90 new agents 
160 
disease_progression 
H-positive risk:  674 644 93 1103 411 95 1108 407 159 53 183 70 
H-negative risk:  644 674 1108 1103 407 411 95 93 183 159 70 53 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 82 19 

clinical_engagement 
diagnosis 
demography 
81 new agents 
161 
disease_progression 
H-positive risk:  669 645 96 1114 409 97 1108 403 158 53 179 69 
H-negative risk:  645 669 1108 1114 403 409 97 96 179 158 69 53 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 78 19 

clinical_engagement 
diagnosis 
demography 
75 new agents 
162 
disease_progression 
H-positive risk:  679 644 97 1113 405 98 1102 401 159 54 180 68 
H-negative risk:  644 679 1102 1113 401 405 98 97 180 159 68 54 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 78 19 

clinical_engagement 
diagnosis 
demography 
87 new agents 
163 
disease_progression 
H-positive risk:  679 650 99 1110 409 97 1095 400 157 58 179 67 
H-negative risk:  650 679 1095 1110 400 409 97 99 179 157 67 58 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 79 19 

clinical_engagement 
diagnosis 
demography 
66 new agents 
164 
disease_progression 
H-positive risk:  675 650 98 1115 411 97 1096 402 157 58 173 68 
H-negative risk:  650 675 1096 1115 402 411 97 98 173 157 68 58 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 82 19 

clinical_engagement 
diagnosis 
demography 
75 new agents 
165 
disease_progression 
H-positive risk:  679 644 98 1116 409 97 1108 399 158 55 170 67 
H-negative risk:  644 679 1108 1116 399 409 97 98 170 158 67 55 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 81 21 

clinical_engagement 
diagnosis 
demography 
59 new agents 
166 
disease_progression 
H-positive risk:  676 635 98 1123 418 97 1117 389 155 55 172 65 
H-negative risk:  635 676 1117 1123 389 418 97 98 172 155 65 55 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 84 21 

clinical_engagement 
diagnosis 
demography 
77 new agents 
167 
disease_progression 
H-positive risk:  679 631 100 1123 418 97 1117 388 154 54 178 61 
H-negative risk:  631 679 1117 1123 388 418 97 100 178 154 61 54 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 84 20 

clinical_engagement 
diagnosis 
demography 
77 new agents 
168 
disease_progression 
H-positive risk:  683 627 102 1127 420 94 1114 389 159 51 174 60 
H-negative risk:  627 683 1114 1127 389 420 94 102 174 159 60 51 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 86 19 

clinical_engagement 
diagnosis 
demography 
88 new agents 
169 
disease_progression 
H-positive risk:  690 629 103 1119 419 94 1114 392 161 50 172 57 
H-negative risk:  629 690 1114 1119 392 419 94 103 172 161 57 50 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 86 18 

clinical_engagement 
diagnosis 
demography 
89 new agents 
170 
disease_progression 
H-positive risk:  686 637 103 1113 427 98 1107 389 162 49 172 57 
H-negative risk:  637 686 1107 1113 389 427 98 103 172 162 57 49 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 85 19 

clinical_engagement 
diagnosis 
demography 
65 new agents 
171 
disease_progression 
H-positive risk:  688 639 103 1117 426 98 1108 378 162 51 174 56 
H-negative risk:  639 688 1108 1117 378 426 98 103 174 162 56 51 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 84 18 

clinical_engagement 
diagnosis 
demography 
85 new agents 
172 
disease_progression 
H-positive risk:  682 638 101 1121 421 99 1108 388 163 51 172 56 
H-negative risk:  638 682 1108 1121 388 421 99 101 172 163 56 51 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 85 18 

clinical_engagement 
diagnosis 
demography 
69 new agents 
173 
disease_progression 
H-positive risk:  682 632 100 1119 424 103 1113 379 164 53 176 55 
H-negative risk:  632 682 1113 1119 379 424 103 100 176 164 55 53 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 86 19 

clinical_engagement 
diagnosis 
demography 
81 new agents 
174 
disease_progression 
H-positive risk:  684 642 95 1114 417 104 1116 380 161 56 177 54 
H-negative risk:  642 684 1116 1114 380 417 104 95 177 161 54 56 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 87 18 

clinical_engagement 
diagnosis 
demography 
67 new agents 
175 
disease_progression 
H-positive risk:  689 636 97 1098 420 107 1116 381 163 59 179 55 
H-negative risk:  636 689 1116 1098 381 420 107 97 179 163 55 59 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 88 18 

clinical_engagement 
diagnosis 
demography 
65 new agents 
176 
disease_progression 
H-positive risk:  685 635 99 1099 422 107 1119 380 160 59 178 57 
H-negative risk:  635 685 1119 1099 380 422 107 99 178 160 57 59 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 86 18 

clinical_engagement 
diagnosis 
demography 
104 new agents 
177 
disease_progression 
H-positive risk:  681 642 96 1091 413 106 1128 386 164 57 178 58 
H-negative risk:  642 681 1128 1091 386 413 106 96 178 164 58 57 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 82 16 

clinical_engagement 
diagnosis 
demography 
83 new agents 
178 
disease_progression 
H-positive risk:  685 644 95 1084 411 106 1134 387 162 56 177 59 
H-negative risk:  644 685 1134 1084 387 411 106 95 177 162 59 56 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 81 18 

clinical_engagement 
diagnosis 
demography 
68 new agents 
179 
disease_progression 
H-positive risk:  687 638 95 1081 414 108 1129 396 164 54 174 60 
H-negative risk:  638 687 1129 1081 396 414 108 95 174 164 60 54 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 76 18 

clinical_engagement 
diagnosis 
demography 
73 new agents 
180 
disease_progression 
H-positive risk:  686 637 91 1077 416 105 1126 402 165 55 175 65 
H-negative risk:  637 686 1126 1077 402 416 105 91 175 165 65 55 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 79 17 

clinical_engagement 
diagnosis 
demography 
71 new agents 
181 
disease_progression 
H-positive risk:  694 641 94 1070 414 105 1130 395 167 53 174 63 
H-negative risk:  641 694 1130 1070 395 414 105 94 174 167 63 53 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 80 17 

clinical_engagement 
diagnosis 
demography 
91 new agents 
182 
disease_progression 
H-positive risk:  697 646 93 1075 421 102 1103 406 169 52 174 62 
H-negative risk:  646 697 1103 1075 406 421 102 93 174 169 62 52 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 78 21 

clinical_engagement 
diagnosis 
demography 
61 new agents 
183 
disease_progression 
H-positive risk:  699 647 94 1076 423 102 1088 410 171 53 175 62 
H-negative risk:  647 699 1088 1076 410 423 102 94 175 171 62 53 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 79 22 

clinical_engagement 
diagnosis 
demography 
72 new agents 
184 
disease_progression 
H-positive risk:  694 642 96 1083 424 103 1088 412 170 55 172 61 
H-negative risk:  642 694 1088 1083 412 424 103 96 172 170 61 55 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 77 23 

clinical_engagement 
diagnosis 
demography 
82 new agents 
185 
disease_progression 
H-positive risk:  690 647 98 1091 422 104 1088 400 167 57 172 64 
H-negative risk:  647 690 1088 1091 400 422 104 98 172 167 64 57 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 82 23 

clinical_engagement 
diagnosis 
demography 
72 new agents 
186 
disease_progression 
H-positive risk:  687 639 97 1094 425 108 1089 402 166 59 170 64 
H-negative risk:  639 687 1089 1094 402 425 108 97 170 166 64 59 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 82 23 

clinical_engagement 
diagnosis 
demography 
88 new agents 
187 
disease_progression 
H-positive risk:  691 644 96 1093 423 110 1076 411 166 58 166 66 
H-negative risk:  644 691 1076 1093 411 423 110 96 166 166 66 58 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 85 22 

clinical_engagement 
diagnosis 
demography 
71 new agents 
188 
disease_progression 
H-positive risk:  693 643 97 1092 426 111 1083 403 165 59 162 66 
H-negative risk:  643 693 1083 1092 403 426 111 97 162 165 66 59 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 86 21 

clinical_engagement 
diagnosis 
demography 
58 new agents 
189 
disease_progression 
H-positive risk:  686 641 97 1091 426 112 1087 406 164 61 160 69 
H-negative risk:  641 686 1087 1091 406 426 112 97 160 164 69 61 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 87 21 

clinical_engagement 
diagnosis 
demography 
61 new agents 
190 
disease_progression 
H-positive risk:  684 643 98 1090 427 110 1087 408 165 62 157 69 
H-negative risk:  643 684 1087 1090 408 427 110 98 157 165 69 62 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 88 20 

clinical_engagement 
diagnosis 
demography 
69 new agents 
191 
disease_progression 
H-positive risk:  681 642 99 1090 429 111 1083 414 164 63 155 69 
H-negative risk:  642 681 1083 1090 414 429 111 99 155 164 69 63 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 86 20 

clinical_engagement 
diagnosis 
demography 
64 new agents 
192 
disease_progression 
H-positive risk:  685 641 97 1087 427 111 1084 414 163 65 157 69 
H-negative risk:  641 685 1084 1087 414 427 111 97 157 163 69 65 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 84 22 

clinical_engagement 
diagnosis 
demography 
111 new agents 
193 
disease_progression 
H-positive risk:  688 639 96 1099 415 110 1084 412 164 66 155 72 
H-negative risk:  639 688 1084 1099 412 415 110 96 155 164 72 66 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 83 22 

clinical_engagement 
diagnosis 
demography 
78 new agents 
194 
disease_progression 
H-positive risk:  697 633 94 1097 412 112 1075 420 162 70 158 70 
H-negative risk:  633 697 1075 1097 420 412 112 94 158 162 70 70 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 82 22 

clinical_engagement 
diagnosis 
demography 
108 new agents 
195 
disease_progression 
H-positive risk:  693 641 95 1096 405 113 1079 420 159 72 157 70 
H-negative risk:  641 693 1079 1096 420 405 113 95 157 159 70 72 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 79 23 

clinical_engagement 
diagnosis 
demography 
72 new agents 
196 
disease_progression 
H-positive risk:  691 637 94 1094 406 114 1077 428 159 72 157 71 
H-negative risk:  637 691 1077 1094 428 406 114 94 157 159 71 72 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 79 26 

clinical_engagement 
diagnosis 
demography 
80 new agents 
197 
disease_progression 
H-positive risk:  691 635 90 1097 410 110 1087 419 161 70 161 69 
H-negative risk:  635 691 1087 1097 419 410 110 90 161 161 69 70 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 77 26 

clinical_engagement 
diagnosis 
demography 
86 new agents 
198 
disease_progression 
H-positive risk:  690 637 91 1088 414 112 1091 414 162 71 162 68 
H-negative risk:  637 690 1091 1088 414 414 112 91 162 162 68 71 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 75 26 

clinical_engagement 
diagnosis 
demography 
64 new agents 
199 
disease_progression 
H-positive risk:  689 645 91 1082 413 111 1086 417 165 70 163 68 
H-negative risk:  645 689 1086 1082 417 413 111 91 163 165 68 70 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 73 25 

clinical_engagement 
diagnosis 
demography 
70 new agents 
200 
disease_progression 
H-positive risk:  690 640 92 1086 420 111 1082 417 163 67 162 70 
H-negative risk:  640 690 1082 1086 417 420 111 92 162 163 70 67 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 73 25 

clinical_engagement 
diagnosis 
demography 
76 new agents 
201 
disease_progression 
H-positive risk:  689 644 92 1079 419 115 1080 421 165 67 160 69 
H-negative risk:  644 689 1080 1079 421 419 115 92 160 165 69 67 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 70 25 

clinical_engagement 
diagnosis 
demography 
70 new agents 
202 
disease_progression 
H-positive risk:  689 637 90 1083 427 116 1082 415 166 64 162 69 
H-negative risk:  637 689 1082 1083 415 427 116 90 162 166 69 64 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 68 24 

clinical_engagement 
diagnosis 
demography 
69 new agents 
203 
disease_progression 
H-positive risk:  695 636 91 1088 420 119 1074 421 163 63 162 68 
H-negative risk:  636 695 1074 1088 421 420 119 91 162 163 68 63 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 67 24 

clinical_engagement 
diagnosis 
demography 
75 new agents 
204 
disease_progression 
H-positive risk:  695 635 96 1086 422 121 1068 420 162 65 162 68 
H-negative risk:  635 695 1068 1086 420 422 121 96 162 162 68 65 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 66 24 

clinical_engagement 
diagnosis 
demography 
67 new agents 
205 
disease_progression 
H-positive risk:  687 637 94 1091 421 121 1070 424 162 66 162 65 
H-negative risk:  637 687 1070 1091 424 421 121 94 162 162 65 66 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 66 24 

clinical_engagement 
diagnosis 
demography 
76 new agents 
206 
disease_progression 
H-positive risk:  689 646 93 1081 425 122 1049 441 161 66 160 67 
H-negative risk:  646 689 1049 1081 441 425 122 93 160 161 67 66 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 66 23 

clinical_engagement 
diagnosis 
demography 
62 new agents 
207 
disease_progression 
H-positive risk:  684 647 91 1073 432 120 1051 448 164 65 161 64 
H-negative risk:  647 684 1051 1073 448 432 120 91 161 164 64 65 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 67 24 

clinical_engagement 
diagnosis 
demography 
72 new agents 
208 
disease_progression 
H-positive risk:  682 646 91 1075 442 123 1049 441 162 62 161 66 
H-negative risk:  646 682 1049 1075 441 442 123 91 161 162 66 62 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 67 24 

clinical_engagement 
diagnosis 
demography 
76 new agents 
209 
disease_progression 
H-positive risk:  690 646 92 1075 440 122 1042 442 160 63 159 69 
H-negative risk:  646 690 1042 1075 442 440 122 92 159 160 69 63 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 68 23 

clinical_engagement 
diagnosis 
demography 
77 new agents 
210 
disease_progression 
H-positive risk:  691 658 94 1067 436 122 1040 445 161 60 159 67 
H-negative risk:  658 691 1040 1067 445 436 122 94 159 161 67 60 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 65 24 

clinical_engagement 
diagnosis 
demography 
74 new agents 
211 
disease_progression 
H-positive risk:  696 656 92 1068 438 118 1043 439 162 62 157 69 
H-negative risk:  656 696 1043 1068 439 438 118 92 157 162 69 62 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 68 24 

clinical_engagement 
diagnosis 
demography 
76 new agents 
212 
disease_progression 
H-positive risk:  694 655 92 1075 441 119 1036 441 162 60 156 69 
H-negative risk:  655 694 1036 1075 441 441 119 92 156 162 69 60 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 69 24 

clinical_engagement 
diagnosis 
demography 
68 new agents 
213 
disease_progression 
H-positive risk:  689 650 91 1077 434 118 1045 444 166 60 157 69 
H-negative risk:  650 689 1045 1077 444 434 118 91 157 166 69 60 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 69 25 

clinical_engagement 
diagnosis 
demography 
73 new agents 
214 
disease_progression 
H-positive risk:  677 651 93 1082 435 121 1048 441 167 61 156 68 
H-negative risk:  651 677 1048 1082 441 435 121 93 156 167 68 61 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 71 25 

clinical_engagement 
diagnosis 
demography 
76 new agents 
215 
disease_progression 
H-positive risk:  676 650 91 1089 431 123 1043 443 165 60 159 70 
H-negative risk:  650 676 1043 1089 443 431 123 91 159 165 70 60 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 73 25 

clinical_engagement 
diagnosis 
demography 
80 new agents 
216 
disease_progression 
H-positive risk:  675 647 90 1090 435 122 1038 443 167 59 163 71 
H-negative risk:  647 675 1038 1090 443 435 122 90 163 167 71 59 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 76 25 

clinical_engagement 
diagnosis 
demography 
80 new agents 
217 
disease_progression 
H-positive risk:  673 635 90 1103 433 123 1020 461 164 63 164 71 
H-negative risk:  635 673 1020 1103 461 433 123 90 164 164 71 63 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 77 25 

clinical_engagement 
diagnosis 
demography 
82 new agents 
218 
disease_progression 
H-positive risk:  666 638 90 1100 432 127 1022 460 162 64 167 72 
H-negative risk:  638 666 1022 1100 460 432 127 90 167 162 72 64 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 78 25 

clinical_engagement 
diagnosis 
demography 
101 new agents 
219 
disease_progression 
H-positive risk:  667 638 91 1095 432 131 1018 461 162 63 169 73 
H-negative risk:  638 667 1018 1095 461 432 131 91 169 162 73 63 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 75 23 

clinical_engagement 
diagnosis 
demography 
62 new agents 
220 
disease_progression 
H-positive risk:  665 643 92 1089 431 128 1023 458 164 63 171 73 
H-negative risk:  643 665 1023 1089 458 431 128 92 171 164 73 63 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 76 23 

clinical_engagement 
diagnosis 
demography 
64 new agents 
221 
disease_progression 
H-positive risk:  670 644 89 1087 423 126 1024 461 163 66 174 73 
H-negative risk:  644 670 1024 1087 461 423 126 89 174 163 73 66 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 79 23 

clinical_engagement 
diagnosis 
demography 
73 new agents 
222 
disease_progression 
H-positive risk:  675 650 88 1086 420 124 1018 461 164 70 170 74 
H-negative risk:  650 675 1018 1086 461 420 124 88 170 164 74 70 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 80 22 

clinical_engagement 
diagnosis 
demography 
66 new agents 
223 
disease_progression 
H-positive risk:  678 640 90 1095 423 122 1018 461 168 66 168 71 
H-negative risk:  640 678 1018 1095 461 423 122 90 168 168 71 66 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 81 21 

clinical_engagement 
diagnosis 
demography 
68 new agents 
224 
disease_progression 
H-positive risk:  677 641 91 1089 426 123 1018 465 169 68 168 65 
H-negative risk:  641 677 1018 1089 465 426 123 91 168 169 65 68 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 84 22 

clinical_engagement 
diagnosis 
demography 
72 new agents 
225 
disease_progression 
H-positive risk:  682 641 94 1086 425 122 1016 463 172 66 168 65 
H-negative risk:  641 682 1016 1086 463 425 122 94 168 172 65 66 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 86 20 

clinical_engagement 
diagnosis 
demography 
85 new agents 
226 
disease_progression 
H-positive risk:  683 642 91 1086 420 122 1019 467 169 65 174 62 
H-negative risk:  642 683 1019 1086 467 420 122 91 174 169 62 65 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 86 20 

clinical_engagement 
diagnosis 
demography 
66 new agents 
227 
disease_progression 
H-positive risk:  682 646 92 1081 417 120 1018 475 170 66 173 60 
H-negative risk:  646 682 1018 1081 475 417 120 92 173 170 60 66 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 86 19 

clinical_engagement 
diagnosis 
demography 
101 new agents 
228 
disease_progression 
H-positive risk:  695 649 92 1087 422 121 1008 468 170 62 169 57 
H-negative risk:  649 695 1008 1087 468 422 121 92 169 170 57 62 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 89 19 

clinical_engagement 
diagnosis 
demography 
77 new agents 
229 
disease_progression 
H-positive risk:  699 654 89 1082 426 123 999 471 167 63 171 56 
H-negative risk:  654 699 999 1082 471 426 123 89 171 167 56 63 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 91 19 

clinical_engagement 
diagnosis 
demography 
103 new agents 
230 
disease_progression 
H-positive risk:  709 655 91 1083 429 119 991 466 171 60 171 55 
H-negative risk:  655 709 991 1083 466 429 119 91 171 171 55 60 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 88 18 

clinical_engagement 
diagnosis 
demography 
69 new agents 
231 
disease_progression 
H-positive risk:  713 647 87 1079 437 117 991 472 175 55 171 56 
H-negative risk:  647 713 991 1079 472 437 117 87 171 175 56 55 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 87 16 

clinical_engagement 
diagnosis 
demography 
90 new agents 
232 
disease_progression 
H-positive risk:  721 645 89 1070 427 118 1000 473 175 54 172 56 
H-negative risk:  645 721 1000 1070 473 427 118 89 172 175 56 54 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 88 14 

clinical_engagement 
diagnosis 
demography 
79 new agents 
233 
disease_progression 
H-positive risk:  716 644 92 1074 427 119 999 473 179 51 171 55 
H-negative risk:  644 716 999 1074 473 427 119 92 171 179 55 51 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 91 15 

clinical_engagement 
diagnosis 
demography 
66 new agents 
234 
disease_progression 
H-positive risk:  714 642 95 1071 433 116 1004 470 180 54 172 49 
H-negative risk:  642 714 1004 1071 470 433 116 95 172 180 49 54 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 93 15 

clinical_engagement 
diagnosis 
demography 
66 new agents 
235 
disease_progression 
H-positive risk:  714 638 96 1076 426 114 1014 466 182 56 168 50 
H-negative risk:  638 714 1014 1076 466 426 114 96 168 182 50 56 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 93 14 

clinical_engagement 
diagnosis 
demography 
56 new agents 
236 
disease_progression 
H-positive risk:  708 642 96 1067 434 113 1019 462 181 59 169 50 
H-negative risk:  642 708 1019 1067 462 434 113 96 169 181 50 59 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 96 15 

clinical_engagement 
diagnosis 
demography 
86 new agents 
237 
disease_progression 
H-positive risk:  705 641 95 1071 437 112 1019 458 180 60 171 51 
H-negative risk:  641 705 1019 1071 458 437 112 95 171 180 51 60 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 98 15 

clinical_engagement 
diagnosis 
demography 
91 new agents 
238 
disease_progression 
H-positive risk:  709 644 96 1070 432 115 1025 447 177 61 174 50 
H-negative risk:  644 709 1025 1070 447 432 115 96 174 177 50 61 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 97 18 

clinical_engagement 
diagnosis 
demography 
70 new agents 
239 
disease_progression 
H-positive risk:  710 651 96 1060 434 118 1020 447 176 61 175 52 
H-negative risk:  651 710 1020 1060 447 434 118 96 175 176 52 61 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 96 20 

clinical_engagement 
diagnosis 
demography 
78 new agents 
240 
disease_progression 
H-positive risk:  709 652 91 1052 434 120 1029 445 176 62 178 52 
H-negative risk:  652 709 1029 1052 445 434 120 91 178 176 52 62 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 95 22 

clinical_engagement 
diagnosis 
demography 
92 new agents 
241 
disease_progression 
H-positive risk:  717 650 92 1044 438 120 1021 448 173 65 178 54 
H-negative risk:  650 717 1021 1044 448 438 120 92 178 173 54 65 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 95 23 

clinical_engagement 
diagnosis 
demography 
84 new agents 
242 
disease_progression 
H-positive risk:  726 652 93 1051 427 120 1023 437 171 68 177 55 
H-negative risk:  652 726 1023 1051 437 427 120 93 177 171 55 68 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 92 23 

clinical_engagement 
diagnosis 
demography 
87 new agents 
243 
disease_progression 
H-positive risk:  730 649 94 1048 427 117 1022 444 169 68 175 57 
H-negative risk:  649 730 1022 1048 444 427 117 94 175 169 57 68 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 94 22 

clinical_engagement 
diagnosis 
demography 
82 new agents 
244 
disease_progression 
H-positive risk:  726 652 94 1059 428 113 1020 441 167 69 176 55 
H-negative risk:  652 726 1020 1059 441 428 113 94 176 167 55 69 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 94 22 

clinical_engagement 
diagnosis 
demography 
70 new agents 
245 
disease_progression 
H-positive risk:  721 651 95 1062 423 112 1024 442 166 71 177 56 
H-negative risk:  651 721 1024 1062 442 423 112 95 177 166 56 71 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 95 22 

clinical_engagement 
diagnosis 
demography 
92 new agents 
246 
disease_progression 
H-positive risk:  721 651 97 1061 430 114 1018 445 166 69 173 55 
H-negative risk:  651 721 1018 1061 445 430 114 97 173 166 55 69 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 97 22 

clinical_engagement 
diagnosis 
demography 
83 new agents 
247 
disease_progression 
H-positive risk:  722 650 95 1056 423 113 1023 450 168 71 173 56 
H-negative risk:  650 722 1023 1056 450 423 113 95 173 168 56 71 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 97 22 

clinical_engagement 
diagnosis 
demography 
89 new agents 
248 
disease_progression 
H-positive risk:  725 654 97 1049 426 112 1015 453 172 69 173 55 
H-negative risk:  654 725 1015 1049 453 426 112 97 173 172 55 69 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 95 22 

clinical_engagement 
diagnosis 
demography 
80 new agents 
249 
disease_progression 
H-positive risk:  720 653 98 1051 420 113 1020 453 174 69 175 54 
H-negative risk:  653 720 1020 1051 453 420 113 98 175 174 54 69 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 95 22 

clinical_engagement 
diagnosis 
demography 
77 new agents 
250 
disease_progression 
H-positive risk:  725 664 100 1054 413 113 1021 450 170 65 172 53 
H-negative risk:  664 725 1021 1054 450 413 113 100 172 170 53 65 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 97 22 

clinical_engagement 
diagnosis 
demography 
75 new agents 
251 
disease_progression 
H-positive risk:  722 664 95 1041 427 109 1028 451 171 61 177 54 
H-negative risk:  664 722 1028 1041 451 427 109 95 177 171 54 61 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 98 22 

clinical_engagement 
diagnosis 
demography 
75 new agents 
252 
disease_progression 
H-positive risk:  710 662 97 1054 427 112 1039 438 173 59 177 52 
H-negative risk:  662 710 1039 1054 438 427 112 97 177 173 52 59 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 98 22 

clinical_engagement 
diagnosis 
demography 
58 new agents 
253 
disease_progression 
H-positive risk:  711 660 97 1059 423 112 1037 439 174 60 177 51 
H-negative risk:  660 711 1037 1059 439 423 112 97 177 174 51 60 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 96 22 

clinical_engagement 
diagnosis 
demography 
82 new agents 
254 
disease_progression 
H-positive risk:  705 656 95 1058 424 114 1047 440 176 60 173 52 
H-negative risk:  656 705 1047 1058 440 424 114 95 173 176 52 60 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 98 22 

clinical_engagement 
diagnosis 
demography 
87 new agents 
255 
disease_progression 
H-positive risk:  708 657 101 1049 432 113 1052 431 175 62 170 50 
H-negative risk:  657 708 1052 1049 431 432 113 101 170 175 50 62 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 100 21 

clinical_engagement 
diagnosis 
demography 
60 new agents 
256 
disease_progression 
H-positive risk:  699 653 102 1049 434 112 1057 426 183 63 171 51 
H-negative risk:  653 699 1057 1049 426 434 112 102 171 183 51 63 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 103 21 

clinical_engagement 
diagnosis 
demography 
76 new agents 
257 
disease_progression 
H-positive risk:  696 654 103 1053 431 113 1061 425 178 68 165 53 
H-negative risk:  654 696 1061 1053 425 431 113 103 165 178 53 68 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 99 20 

clinical_engagement 
diagnosis 
demography 
72 new agents 
258 
disease_progression 
H-positive risk:  699 654 104 1049 425 114 1057 433 178 70 164 53 
H-negative risk:  654 699 1057 1049 433 425 114 104 164 178 53 70 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 94 19 

clinical_engagement 
diagnosis 
demography 
82 new agents 
259 
disease_progression 
H-positive risk:  700 660 109 1047 423 114 1049 437 175 70 162 54 
H-negative risk:  660 700 1049 1047 437 423 114 109 162 175 54 70 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 95 18 

clinical_engagement 
diagnosis 
demography 
77 new agents 
260 
disease_progression 
H-positive risk:  705 664 109 1048 417 114 1044 441 173 70 160 55 
H-negative risk:  664 705 1044 1048 441 417 114 109 160 173 55 70 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 98 18 

clinical_engagement 
diagnosis 
demography 
68 new agents 
261 
disease_progression 
H-positive risk:  710 658 111 1049 417 111 1039 441 173 73 160 58 
H-negative risk:  658 710 1039 1049 441 417 111 111 160 173 58 73 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 95 19 

clinical_engagement 
diagnosis 
demography 
72 new agents 
262 
disease_progression 
H-positive risk:  714 656 112 1053 410 110 1045 439 173 69 163 56 
H-negative risk:  656 714 1045 1053 439 410 110 112 163 173 56 69 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 94 19 

clinical_engagement 
diagnosis 
demography 
74 new agents 
263 
disease_progression 
H-positive risk:  711 657 113 1047 415 112 1047 438 170 69 165 56 
H-negative risk:  657 711 1047 1047 438 415 112 113 165 170 56 69 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 93 19 

clinical_engagement 
diagnosis 
demography 
75 new agents 
264 
disease_progression 
H-positive risk:  713 661 110 1044 412 106 1049 440 173 67 168 57 
H-negative risk:  661 713 1049 1044 440 412 106 110 168 173 57 67 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 92 19 

clinical_engagement 
diagnosis 
demography 
74 new agents 
265 
disease_progression 
H-positive risk:  717 659 109 1034 412 104 1044 450 177 69 167 58 
H-negative risk:  659 717 1044 1034 450 412 104 109 167 177 58 69 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 91 19 

clinical_engagement 
diagnosis 
demography 
91 new agents 
266 
disease_progression 
H-positive risk:  709 658 109 1032 411 107 1061 440 177 68 170 58 
H-negative risk:  658 709 1061 1032 440 411 107 109 170 177 58 68 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 94 19 

clinical_engagement 
diagnosis 
demography 
91 new agents 
267 
disease_progression 
H-positive risk:  715 654 108 1043 403 106 1061 433 180 71 167 59 
H-negative risk:  654 715 1061 1043 433 403 106 108 167 180 59 71 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 95 17 

clinical_engagement 
diagnosis 
demography 
69 new agents 
268 
disease_progression 
H-positive risk:  717 655 109 1046 402 108 1061 432 179 70 163 58 
H-negative risk:  655 717 1061 1046 432 402 108 109 163 179 58 70 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 95 17 

clinical_engagement 
diagnosis 
demography 
79 new agents 
269 
disease_progression 
H-positive risk:  720 653 106 1052 406 108 1059 430 180 68 161 57 
H-negative risk:  653 720 1059 1052 430 406 108 106 161 180 57 68 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 91 18 

clinical_engagement 
diagnosis 
demography 
71 new agents 
270 
disease_progression 
H-positive risk:  719 654 107 1056 411 109 1052 427 178 68 163 56 
H-negative risk:  654 719 1052 1056 427 411 109 107 163 178 56 68 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 92 18 

clinical_engagement 
diagnosis 
demography 
83 new agents 
271 
disease_progression 
H-positive risk:  720 654 102 1057 407 111 1056 427 177 69 163 57 
H-negative risk:  654 720 1056 1057 427 407 111 102 163 177 57 69 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 90 17 

clinical_engagement 
diagnosis 
demography 
83 new agents 
272 
disease_progression 
H-positive risk:  726 654 107 1060 407 110 1052 415 180 71 162 56 
H-negative risk:  654 726 1052 1060 415 407 110 107 162 180 56 71 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 92 15 

clinical_engagement 
diagnosis 
demography 
79 new agents 
273 
disease_progression 
H-positive risk:  723 658 104 1057 406 113 1055 418 182 67 161 56 
H-negative risk:  658 723 1055 1057 418 406 113 104 161 182 56 67 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 93 13 

clinical_engagement 
diagnosis 
demography 
88 new agents 
274 
disease_progression 
H-positive risk:  721 657 106 1059 404 108 1062 423 181 64 159 56 
H-negative risk:  657 721 1062 1059 423 404 108 106 159 181 56 64 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 93 14 

clinical_engagement 
diagnosis 
demography 
81 new agents 
275 
disease_progression 
H-positive risk:  713 660 106 1048 413 109 1061 427 181 66 158 58 
H-negative risk:  660 713 1061 1048 427 413 109 106 158 181 58 66 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 92 14 

clinical_engagement 
diagnosis 
demography 
81 new agents 
276 
disease_progression 
H-positive risk:  702 673 106 1051 410 109 1061 423 180 68 160 57 
H-negative risk:  673 702 1061 1051 423 410 109 106 160 180 57 68 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 89 16 

clinical_engagement 
diagnosis 
demography 
61 new agents 
277 
disease_progression 
H-positive risk:  696 678 110 1040 415 110 1065 424 178 68 158 58 
H-negative risk:  678 696 1065 1040 424 415 110 110 158 178 58 68 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 90 19 

clinical_engagement 
diagnosis 
demography 
73 new agents 
278 
disease_progression 
H-positive risk:  695 672 109 1047 408 111 1060 433 177 70 160 58 
H-negative risk:  672 695 1060 1047 433 408 111 109 160 177 58 70 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 87 19 

clinical_engagement 
diagnosis 
demography 
60 new agents 
279 
disease_progression 
H-positive risk:  686 674 107 1057 406 109 1054 444 179 69 160 55 
H-negative risk:  674 686 1054 1057 444 406 109 107 160 179 55 69 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 88 19 

clinical_engagement 
diagnosis 
demography 
82 new agents 
280 
disease_progression 
H-positive risk:  681 677 107 1057 404 109 1056 441 176 74 156 62 
H-negative risk:  677 681 1056 1057 441 404 109 107 156 176 62 74 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 87 18 

clinical_engagement 
diagnosis 
demography 
78 new agents 
281 
disease_progression 
H-positive risk:  674 679 107 1060 407 108 1065 438 174 74 152 62 
H-negative risk:  679 674 1065 1060 438 407 108 107 152 174 62 74 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 87 18 

clinical_engagement 
diagnosis 
demography 
86 new agents 
282 
disease_progression 
H-positive risk:  673 681 110 1049 420 109 1067 441 173 68 146 63 
H-negative risk:  681 673 1067 1049 441 420 109 110 146 173 63 68 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 87 17 

clinical_engagement 
diagnosis 
demography 
76 new agents 
283 
disease_progression 
H-positive risk:  674 683 107 1055 414 108 1063 442 174 68 149 63 
H-negative risk:  683 674 1063 1055 442 414 108 107 149 174 63 68 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 89 18 

clinical_engagement 
diagnosis 
demography 
70 new agents 
284 
disease_progression 
H-positive risk:  682 682 106 1062 405 110 1060 440 167 71 152 63 
H-negative risk:  682 682 1060 1062 440 405 110 106 152 167 63 71 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 87 18 

clinical_engagement 
diagnosis 
demography 
79 new agents 
285 
disease_progression 
H-positive risk:  688 683 105 1061 403 108 1056 441 169 70 149 67 
H-negative risk:  683 688 1056 1061 441 403 108 105 149 169 67 70 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 87 17 

clinical_engagement 
diagnosis 
demography 
69 new agents 
286 
disease_progression 
H-positive risk:  691 677 102 1059 403 104 1059 443 171 70 151 70 
H-negative risk:  677 691 1059 1059 443 403 104 102 151 171 70 70 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 87 16 

clinical_engagement 
diagnosis 
demography 
71 new agents 
287 
disease_progression 
H-positive risk:  690 671 104 1067 404 104 1065 438 168 69 150 70 
H-negative risk:  671 690 1065 1067 438 404 104 104 150 168 70 69 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 87 16 

clinical_engagement 
diagnosis 
demography 
75 new agents 
288 
disease_progression 
H-positive risk:  696 673 105 1063 402 101 1066 436 168 71 148 71 
H-negative risk:  673 696 1066 1063 436 402 101 105 148 168 71 71 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 88 18 

clinical_engagement 
diagnosis 
demography 
75 new agents 
289 
disease_progression 
H-positive risk:  697 669 104 1064 406 99 1068 434 169 72 150 68 
H-negative risk:  669 697 1068 1064 434 406 99 104 150 169 68 72 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 86 18 

clinical_engagement 
diagnosis 
demography 
96 new agents 
290 
disease_progression 
H-positive risk:  706 675 102 1066 403 98 1069 429 169 70 145 68 
H-negative risk:  675 706 1069 1066 429 403 98 102 145 169 68 70 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 86 18 

clinical_engagement 
diagnosis 
demography 
69 new agents 
291 
disease_progression 
H-positive risk:  708 676 102 1069 406 101 1063 429 167 65 147 67 
H-negative risk:  676 708 1063 1069 429 406 101 102 147 167 67 65 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 89 19 

clinical_engagement 
diagnosis 
demography 
82 new agents 
292 
disease_progression 
H-positive risk:  703 676 102 1077 404 101 1072 420 163 65 151 66 
H-negative risk:  676 703 1072 1077 420 404 101 102 151 163 66 65 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 89 19 

clinical_engagement 
diagnosis 
demography 
68 new agents 
293 
disease_progression 
H-positive risk:  708 674 102 1081 400 103 1067 418 161 67 152 67 
H-negative risk:  674 708 1067 1081 418 400 103 102 152 161 67 67 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 91 19 

clinical_engagement 
diagnosis 
demography 
64 new agents 
294 
disease_progression 
H-positive risk:  708 677 102 1078 404 101 1066 419 161 67 151 66 
H-negative risk:  677 708 1066 1078 419 404 101 102 151 161 66 67 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 93 19 

clinical_engagement 
diagnosis 
demography 
80 new agents 
295 
disease_progression 
H-positive risk:  711 668 102 1089 408 102 1059 419 158 68 152 64 
H-negative risk:  668 711 1059 1089 419 408 102 102 152 158 64 68 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 91 17 

clinical_engagement 
diagnosis 
demography 
85 new agents 
296 
disease_progression 
H-positive risk:  709 671 100 1087 410 101 1057 424 156 69 151 65 
H-negative risk:  671 709 1057 1087 424 410 101 100 151 156 65 69 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 93 17 

clinical_engagement 
diagnosis 
demography 
94 new agents 
297 
disease_progression 
H-positive risk:  704 677 98 1083 410 101 1068 417 160 68 152 62 
H-negative risk:  677 704 1068 1083 417 410 101 98 152 160 62 68 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 94 19 

clinical_engagement 
diagnosis 
demography 
69 new agents 
298 
disease_progression 
H-positive risk:  703 676 98 1078 412 101 1070 421 157 69 153 62 
H-negative risk:  676 703 1070 1078 421 412 101 98 153 157 62 69 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 95 18 

clinical_engagement 
diagnosis 
demography 
75 new agents 
299 
disease_progression 
H-positive risk:  708 668 97 1080 419 99 1065 421 160 68 154 61 
H-negative risk:  668 708 1065 1080 421 419 99 97 154 160 61 68 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 92 19 

clinical_engagement 
diagnosis 
demography 
83 new agents 
300 
disease_progression 
H-positive risk:  702 668 95 1080 418 97 1065 431 162 67 153 62 
H-negative risk:  668 702 1065 1080 431 418 97 95 153 162 62 67 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 97 18 

clinical_engagement 
diagnosis 
demography 
80 new agents 
301 
disease_progression 
H-positive risk:  693 669 97 1076 421 100 1068 434 158 70 153 61 
H-negative risk:  669 693 1068 1076 434 421 100 97 153 158 61 70 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 96 17 

clinical_engagement 
diagnosis 
demography 
92 new agents 
302 
disease_progression 
H-positive risk:  691 672 98 1086 431 103 1048 428 160 71 152 60 
H-negative risk:  672 691 1048 1086 428 431 103 98 152 160 60 71 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 94 17 

clinical_engagement 
diagnosis 
demography 
77 new agents 
303 
disease_progression 
H-positive risk:  701 679 99 1073 431 104 1049 419 160 74 152 59 
H-negative risk:  679 701 1049 1073 419 431 104 99 152 160 59 74 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 92 19 

clinical_engagement 
diagnosis 
demography 
73 new agents 
304 
disease_progression 
H-positive risk:  705 677 100 1068 434 104 1049 417 162 74 149 61 
H-negative risk:  677 705 1049 1068 417 434 104 100 149 162 61 74 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 91 19 

clinical_engagement 
diagnosis 
demography 
80 new agents 
305 
disease_progression 
H-positive risk:  705 678 99 1068 432 107 1058 413 157 72 149 62 
H-negative risk:  678 705 1058 1068 413 432 107 99 149 157 62 72 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 90 19 

clinical_engagement 
diagnosis 
demography 
75 new agents 
306 
disease_progression 
H-positive risk:  696 682 101 1069 435 104 1054 414 158 72 152 63 
H-negative risk:  682 696 1054 1069 414 435 104 101 152 158 63 72 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 92 19 

clinical_engagement 
diagnosis 
demography 
93 new agents 
307 
disease_progression 
H-positive risk:  690 690 102 1072 428 102 1059 412 158 71 153 63 
H-negative risk:  690 690 1059 1072 412 428 102 102 153 158 63 71 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 91 18 

clinical_engagement 
diagnosis 
demography 
86 new agents 
308 
disease_progression 
H-positive risk:  696 701 97 1067 430 103 1067 391 162 71 151 64 
H-negative risk:  701 696 1067 1067 391 430 103 97 151 162 64 71 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 90 18 

clinical_engagement 
diagnosis 
demography 
75 new agents 
309 
disease_progression 
H-positive risk:  697 696 98 1072 429 102 1067 392 160 71 152 64 
H-negative risk:  696 697 1067 1072 392 429 102 98 152 160 64 71 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 87 20 

clinical_engagement 
diagnosis 
demography 
78 new agents 
310 
disease_progression 
H-positive risk:  696 696 94 1076 427 103 1066 396 159 71 157 59 
H-negative risk:  696 696 1066 1076 396 427 103 94 157 159 59 71 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 85 21 

clinical_engagement 
diagnosis 
demography 
59 new agents 
311 
disease_progression 
H-positive risk:  688 697 93 1076 432 103 1071 394 162 69 158 57 
H-negative risk:  697 688 1071 1076 394 432 103 93 158 162 57 69 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 87 21 

clinical_engagement 
diagnosis 
demography 
72 new agents 
312 
disease_progression 
H-positive risk:  688 705 90 1075 427 100 1071 397 163 69 157 58 
H-negative risk:  705 688 1071 1075 397 427 100 90 157 163 58 69 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 89 20 

clinical_engagement 
diagnosis 
demography 
69 new agents 
313 
disease_progression 
H-positive risk:  691 706 90 1073 429 100 1072 392 163 70 156 58 
H-negative risk:  706 691 1072 1073 392 429 100 90 156 163 58 70 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 85 19 

clinical_engagement 
diagnosis 
demography 
63 new agents 
314 
disease_progression 
H-positive risk:  692 698 92 1065 431 100 1076 398 164 70 155 59 
H-negative risk:  698 692 1076 1065 398 431 100 92 155 164 59 70 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 86 20 

clinical_engagement 
diagnosis 
demography 
92 new agents 
315 
disease_progression 
H-positive risk:  687 703 95 1057 441 96 1080 401 162 72 153 53 
H-negative risk:  703 687 1080 1057 401 441 96 95 153 162 53 72 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 88 19 

clinical_engagement 
diagnosis 
demography 
61 new agents 
316 
disease_progression 
H-positive risk:  690 698 93 1053 447 96 1071 409 162 72 158 51 
H-negative risk:  698 690 1071 1053 409 447 96 93 158 162 51 72 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 88 20 

clinical_engagement 
diagnosis 
demography 
87 new agents 
317 
disease_progression 
H-positive risk:  692 707 93 1054 443 95 1071 412 162 69 153 49 
H-negative risk:  707 692 1071 1054 412 443 95 93 153 162 49 69 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 84 23 

clinical_engagement 
diagnosis 
demography 
80 new agents 
318 
disease_progression 
H-positive risk:  690 709 93 1053 449 94 1072 408 159 74 152 47 
H-negative risk:  709 690 1072 1053 408 449 94 93 152 159 47 74 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 82 23 

clinical_engagement 
diagnosis 
demography 
76 new agents 
319 
disease_progression 
H-positive risk:  688 707 93 1057 455 92 1077 401 162 70 153 45 
H-negative risk:  707 688 1077 1057 401 455 92 93 153 162 45 70 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 84 25 

clinical_engagement 
diagnosis 
demography 
70 new agents 
320 
disease_progression 
H-positive risk:  685 703 92 1072 460 94 1071 401 153 70 154 45 
H-negative risk:  703 685 1071 1072 401 460 94 92 154 153 45 70 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 81 26 

clinical_engagement 
diagnosis 
demography 
67 new agents 
321 
disease_progression 
H-positive risk:  687 704 91 1074 453 93 1073 404 152 69 154 46 
H-negative risk:  704 687 1073 1074 404 453 93 91 154 152 46 69 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 85 26 

clinical_engagement 
diagnosis 
demography 
79 new agents 
322 
disease_progression 
H-positive risk:  691 708 92 1082 446 92 1069 403 151 68 155 43 
H-negative risk:  708 691 1069 1082 403 446 92 92 155 151 43 68 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 82 24 

clinical_engagement 
diagnosis 
demography 
67 new agents 
323 
disease_progression 
H-positive risk:  690 713 94 1078 443 92 1067 407 148 66 159 43 
H-negative risk:  713 690 1067 1078 407 443 92 94 159 148 43 66 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 83 25 

clinical_engagement 
diagnosis 
demography 
83 new agents 
324 
disease_progression 
H-positive risk:  690 716 94 1079 440 93 1070 403 146 66 158 45 
H-negative risk:  716 690 1070 1079 403 440 93 94 158 146 45 66 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 83 27 

clinical_engagement 
diagnosis 
demography 
72 new agents 
325 
disease_progression 
H-positive risk:  690 712 95 1077 446 92 1065 408 147 66 156 46 
H-negative risk:  712 690 1065 1077 408 446 92 95 156 147 46 66 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 83 29 

clinical_engagement 
diagnosis 
demography 
79 new agents 
326 
disease_progression 
H-positive risk:  686 710 92 1078 442 92 1075 404 146 68 159 48 
H-negative risk:  710 686 1075 1078 404 442 92 92 159 146 48 68 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 82 28 

clinical_engagement 
diagnosis 
demography 
62 new agents 
327 
disease_progression 
H-positive risk:  679 710 91 1076 441 91 1081 409 148 67 159 48 
H-negative risk:  710 679 1081 1076 409 441 91 91 159 148 48 67 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 81 30 

clinical_engagement 
diagnosis 
demography 
70 new agents 
328 
disease_progression 
H-positive risk:  681 712 89 1064 444 90 1086 414 145 68 160 47 
H-negative risk:  712 681 1086 1064 414 444 90 89 160 145 47 68 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 83 30 

clinical_engagement 
diagnosis 
demography 
80 new agents 
329 
disease_progression 
H-positive risk:  674 713 85 1074 444 88 1089 411 144 70 159 49 
H-negative risk:  713 674 1089 1074 411 444 88 85 159 144 49 70 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 86 31 

clinical_engagement 
diagnosis 
demography 
100 new agents 
330 
disease_progression 
H-positive risk:  663 714 88 1076 441 90 1088 417 148 68 158 49 
H-negative risk:  714 663 1088 1076 417 441 90 88 158 148 49 68 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 84 32 

clinical_engagement 
diagnosis 
demography 
69 new agents 
331 
disease_progression 
H-positive risk:  660 714 87 1081 438 90 1092 416 149 66 159 48 
H-negative risk:  714 660 1092 1081 416 438 90 87 159 149 48 66 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 84 35 

clinical_engagement 
diagnosis 
demography 
75 new agents 
332 
disease_progression 
H-positive risk:  663 710 88 1084 429 89 1083 426 150 68 158 52 
H-negative risk:  710 663 1083 1084 426 429 89 88 158 150 52 68 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 83 35 

clinical_engagement 
diagnosis 
demography 
69 new agents 
333 
disease_progression 
H-positive risk:  659 714 91 1073 431 89 1090 423 149 69 160 52 
H-negative risk:  714 659 1090 1073 423 431 89 91 160 149 52 69 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 81 35 

clinical_engagement 
diagnosis 
demography 
79 new agents 
334 
disease_progression 
H-positive risk:  656 716 89 1076 431 89 1098 417 146 67 165 50 
H-negative risk:  716 656 1098 1076 417 431 89 89 165 146 50 67 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 79 34 

clinical_engagement 
diagnosis 
demography 
89 new agents 
335 
disease_progression 
H-positive risk:  652 718 89 1083 424 92 1096 417 148 67 166 48 
H-negative risk:  718 652 1096 1083 417 424 92 89 166 148 48 67 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 78 35 

clinical_engagement 
diagnosis 
demography 
72 new agents 
336 
disease_progression 
H-positive risk:  654 708 89 1093 418 92 1100 415 151 66 165 49 
H-negative risk:  708 654 1100 1093 415 418 92 89 165 151 49 66 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 76 33 

clinical_engagement 
diagnosis 
demography 
74 new agents 
337 
disease_progression 
H-positive risk:  663 709 91 1098 405 90 1098 415 156 62 166 47 
H-negative risk:  709 663 1098 1098 415 405 90 91 166 156 47 62 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 74 32 

clinical_engagement 
diagnosis 
demography 
81 new agents 
338 
disease_progression 
H-positive risk:  654 710 94 1106 397 88 1102 412 160 60 170 47 
H-negative risk:  710 654 1102 1106 412 397 88 94 170 160 47 60 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 73 32 

clinical_engagement 
diagnosis 
demography 
73 new agents 
339 
disease_progression 
H-positive risk:  658 709 91 1109 398 87 1103 407 164 58 171 45 
H-negative risk:  709 658 1103 1109 407 398 87 91 171 164 45 58 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 73 32 

clinical_engagement 
diagnosis 
demography 
84 new agents 
340 
disease_progression 
H-positive risk:  658 706 92 1109 392 89 1109 404 163 60 168 50 
H-negative risk:  706 658 1109 1109 404 392 89 92 168 163 50 60 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 71 32 

clinical_engagement 
diagnosis 
demography 
79 new agents 
341 
disease_progression 
H-positive risk:  667 712 91 1103 390 88 1112 396 162 59 170 50 
H-negative risk:  712 667 1112 1103 396 390 88 91 170 162 50 59 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 71 30 

clinical_engagement 
diagnosis 
demography 
75 new agents 
342 
disease_progression 
H-positive risk:  667 716 91 1098 382 88 1117 395 161 60 173 52 
H-negative risk:  716 667 1117 1098 395 382 88 91 173 161 52 60 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 72 29 

clinical_engagement 
diagnosis 
demography 
71 new agents 
343 
disease_progression 
H-positive risk:  664 717 93 1093 385 83 1124 396 160 63 172 50 
H-negative risk:  717 664 1124 1093 396 385 83 93 172 160 50 63 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 70 28 

clinical_engagement 
diagnosis 
demography 
72 new agents 
344 
disease_progression 
H-positive risk:  656 710 92 1092 391 85 1132 394 161 64 175 48 
H-negative risk:  710 656 1132 1092 394 391 85 92 175 161 48 64 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 70 27 

clinical_engagement 
diagnosis 
demography 
79 new agents 
345 
disease_progression 
H-positive risk:  653 709 92 1091 395 85 1138 385 163 65 176 48 
H-negative risk:  709 653 1138 1091 385 395 85 92 176 163 48 65 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 72 27 

clinical_engagement 
diagnosis 
demography 
65 new agents 
346 
disease_progression 
H-positive risk:  655 707 89 1096 393 85 1136 389 160 67 173 50 
H-negative risk:  707 655 1136 1096 389 393 85 89 173 160 50 67 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 74 28 

clinical_engagement 
diagnosis 
demography 
75 new agents 
347 
disease_progression 
H-positive risk:  648 708 90 1101 390 86 1132 399 160 63 174 49 
H-negative risk:  708 648 1132 1101 399 390 86 90 174 160 49 63 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 72 30 

clinical_engagement 
diagnosis 
demography 
79 new agents 
348 
disease_progression 
H-positive risk:  646 714 92 1090 392 88 1138 392 159 64 175 50 
H-negative risk:  714 646 1138 1090 392 392 88 92 175 159 50 64 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 74 30 

clinical_engagement 
diagnosis 
demography 
77 new agents 
349 
disease_progression 
H-positive risk:  644 724 89 1081 392 86 1144 389 159 63 177 52 
H-negative risk:  724 644 1144 1081 389 392 86 89 177 159 52 63 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 78 30 

clinical_engagement 
diagnosis 
demography 
75 new agents 
350 
disease_progression 
H-positive risk:  647 723 89 1086 389 87 1134 396 156 62 179 52 
H-negative risk:  723 647 1134 1086 396 389 87 89 179 156 52 62 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 78 30 

clinical_engagement 
diagnosis 
demography 
84 new agents 
351 
disease_progression 
H-positive risk:  656 722 91 1088 386 88 1132 393 154 60 178 52 
H-negative risk:  722 656 1132 1088 393 386 88 91 178 154 52 60 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 78 30 

clinical_engagement 
diagnosis 
demography 
87 new agents 
352 
disease_progression 
H-positive risk:  663 729 91 1082 391 92 1115 392 153 60 179 53 
H-negative risk:  729 663 1115 1082 392 391 92 91 179 153 53 60 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 75 28 

clinical_engagement 
diagnosis 
demography 
74 new agents 
353 
disease_progression 
H-positive risk:  665 723 92 1091 384 94 1116 394 156 56 178 51 
H-negative risk:  723 665 1116 1091 394 384 94 92 178 156 51 56 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 77 27 

clinical_engagement 
diagnosis 
demography 
74 new agents 
354 
disease_progression 
H-positive risk:  667 716 94 1089 387 91 1116 397 162 55 176 50 
H-negative risk:  716 667 1116 1089 397 387 91 94 176 162 50 55 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 74 28 

clinical_engagement 
diagnosis 
demography 
69 new agents 
355 
disease_progression 
H-positive risk:  666 701 96 1097 394 93 1118 389 160 56 176 54 
H-negative risk:  701 666 1118 1097 389 394 93 96 176 160 54 56 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 74 27 

clinical_engagement 
diagnosis 
demography 
64 new agents 
356 
disease_progression 
H-positive risk:  672 696 93 1100 399 91 1112 389 157 56 180 55 
H-negative risk:  696 672 1112 1100 389 399 91 93 180 157 55 56 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 76 26 

clinical_engagement 
diagnosis 
demography 
70 new agents 
357 
disease_progression 
H-positive risk:  677 687 94 1105 401 90 1114 383 158 55 179 57 
H-negative risk:  687 677 1114 1105 383 401 90 94 179 158 57 55 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 78 25 

clinical_engagement 
diagnosis 
demography 
75 new agents 
358 
disease_progression 
H-positive risk:  672 688 93 1103 403 93 1124 381 157 51 178 57 
H-negative risk:  688 672 1124 1103 381 403 93 93 178 157 57 51 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 78 25 

clinical_engagement 
diagnosis 
demography 
73 new agents 
359 
disease_progression 
H-positive risk:  670 684 92 1102 401 96 1133 384 153 50 175 60 
H-negative risk:  684 670 1133 1102 384 401 96 92 175 153 60 50 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 81 25 

clinical_engagement 
diagnosis 
demography 
82 new agents 
360 
disease_progression 
H-positive risk:  673 683 91 1102 400 97 1126 392 155 47 174 60 
H-negative risk:  683 673 1126 1102 392 400 97 91 174 155 60 47 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 81 22 

clinical_engagement 
diagnosis 
demography 
65 new agents 
Time difference of 18.29955 mins
This is task 9
date
